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ABSTRACT 
 (+)-Tacamonine, a natural product isolated from the Central African plant 
Tabernaemontana eglandulosa, belongs to the relatively new tacaman class of pentacyclic 
monoterpenoid indole alkaloids. Its close structural similarity to the potent cerebral 
vasodilator (-)-vincamone has promoted several efforts towards its synthesis, culminating 
in the appearance of two asymmetric and seven racemic syntheses in the literature. 
 This dissertation details the successful execution of our strategy for the concise, 
highly-efficient, asymmetric total synthesis of (+)-tacamonine. Chapter 1 serves as an 
introduction to the tacaman class, including the proposed biosynthesis for members of this 
class, followed by a review of the reported synthetic approaches to tacamonine. Chapter 2 
details the evolution of our approach based on the use of key radical cyclization 
methodology to ultimately accomplish a total synthesis of the target. An investigation of the 
diastereoselectivity displayed in the radical cyclization step is also described through 
computational methods.  
 Our route followed a novel ABC to ABCD to ABCDE ring-construction strategy, 
which first involved the synthesis of 3,4-dihydro--carboline as well as a chiral acid ester 
fragment that was acquired through Evans’ auxiliary-controlled alkylation chemistry. The 
latter set the absolute configuration at C-20 bearing the ethyl group in the D-ring, and 
thereafter, the two fragments were coupled together before being advanced to the radical 
cyclization precursor. Radical cyclization then led to the formation of the desired cis D/E-
ring junction in a diastereomeric ratio of 10:1, the major diastereomer displaying the 
required C-3/C-14 to C-20 anti-diastereoselectivity. Subsequent global reduction and 
oxidation/E-ring formation processes afforded the target in 8 steps over 10 operations in 
25% overall yield and in 96% enantiomeric excess. X-Ray crystallographic structure 
determination provided conclusive evidence for the formation of the target.  
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1.1 Introduction and Biological Importance 
 Indole alkaloids have been a topic of synthetic interest for decades as a result of the 
important pharmacological properties and complex structural variation that exists within 
this class of natural products.1 These alkaloids, containing the indole structural moiety 
(Figure 1), are further divided into two main types, namely, non-isoprenoid and isoprenoid 
indole alkaloids.2,3 Members of the non-isoprenoid type include simple derivatives of indole 
(1) and -carboline (2) amongst others. In contrast, the isoprenoid indole alkaloids 
incorporate terpenoid structural elements (isoprene groups) in addition to the indole 
subunit (3,4).2,3 
 
Figure 1. An assortment of well-known biologically active indole alkaloids. 
 Monoterpenoid indole alkaloids are also referred to as secologanin tryptamine 
alkaloids stemming from the identification of a tryptamine portion as well as a C9 or C10 
fragment derived from secologanin in their core frameworks (Figure 2).2,3 These alkaloids 
have generally been rationalized in terms of their biosynthetic origins and have 
consequently been subdivided into three main structural types. These are termed the 
Corynanthe type, as in ajmalicine (5), the Iboga type, as in catharanthine (6), and the 
Aspidosperma type, exemplified by tabersonine (7).2,3 
 
Figure 2. Representative monoterpenoid indole alkaloids. 
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 The multifarious structural nature of these types has resulted in the further 
identification of classes or families.2,3 The focus of this work, in particular, is based on two 
closely related classes of the Aspidosperma type, namely, the vinca and tacaman 
classes,2,3 exemplified by key representatives of these classes in Figure 3.  
 
Figure 3. Key members of the vinca and tacaman families respectively. 
 Tacamonine (11), the target of this work, belongs to the tacaman class of 
monoterpene indole alkaloids.1 It was first synthesised in 1982 as a racemate by Massiot 
et al.4 prior to its isolation, known then as pseudovincamone I, making it one of the 
exceptional cases where a natural product has been synthetically prepared before being 
found in Nature.5,6 Thereafter, it was isolated in 1984 by Van Beek and co-workers7 from 
the leaves and twigs of Tabernaemontana eglandulosa, a small liane plant widely 
distributed in forests in Central Africa that occurs usually as solitary plants, flowering 
during the night.7 Traditionally, the roots of Tabernaemontana eglandulosa have been 
used for the treatment of snake bite in the Democratic Republic of Congo, most likely 
stimulating these early investigations.8 In this pioneering work, a total of eight alkaloids 
belonging to the new tacaman class were isolated, with tacamine (10), tacamonine (11), 
16-epi-tacamine (12) as the three most abundant components (Figure 4).7 Structurally, 
these indole alkaloids are all pentacyclic in that they contain an ABCDE five-ring system 
which is in turn made up of the nitrogen-containing indole structural moiety and an 
isoprene subunit (13, Figure 5).1 
 
Figure 4. The three most abundant tacaman alkaloids isolated by Van Beek et al. in 1984.7 
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 In terms of its biological significance, tacamonine (11) bears a close relation to 
vincamone (9), belonging to the vinca class, differing only in the position of the ethyl group 
(Figure 5).9 Members of the vinca family have long since been known to exhibit potent 
cerebral vasodilator and hypotensive activities.1,5,8,9 This close structural similarity has thus 
promoted several efforts towards the synthesis of tacamonine and other members of the 
tacaman family.1,9  
 
Figure 5. Structural similarities and differences between tacamonine and vincamone. 
 Synthetically, attachment of the ethyl group at C-20 away from the D/E-ring junction 
adds an additional stereocenter and thus provides a further degree of complexity to its 
synthesis since all three methine hydrogens at C-3, C-14 and C-20 have to be positioned 
cis relative to each other. 
 
1.2 Biosynthesis 
 In terms of biosynthetic considerations, the exact biosynthetic pathways resulting in 
the derivation of the tacaman class remain unknown.7 As previously mentioned in the 
introductory section, monoterpenoid indole alkaloids of the Aspidosperma type such as 
tabersonine (7) are derived from tryptamine (14) and secologanin (15) as shown in 
Scheme 1.3 Tabersonine (7) is then used in the derivation of the vinca family as 
exemplified by vincamine (8), the mechanism of which was recently confirmed in 2015 by 
Kellner et al.10 The tacaman family is thus thought to be derived in a similar manner from 
pseudotabersonine (16), though this remains to be confirmed.7 
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Scheme 1. Proposed biosynthesis for the vinca and tacaman classes.3,10 
 
1.3 Synthetic Studies in the Tacaman Class 
1.3.1 Syntheses of (±)-Tacamonine  
 In the years following the isolation of natural (+)-tacamomine, two asymmetric total 
syntheses (discussed later on) as well as a total of seven racemic syntheses have been 
reported in the literature, three of which are formal syntheses. As will be seen in the 
upcoming section, the A-B indole ring system (13, Figure 5) is generally introduced 
through coupling of a tryptamine fragment, while in most cases the C-ring is constructed 
via a Bischler-Napieralski cyclization.  
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 In general, the fundamental differences in the synthetic approaches lie in the 
method used to construct the D-ring fragment, the method used to generate the cis D/E-
ring junction, as well as the order in which the pentacyclic core is constructed. Classically, 
most syntheses construct the framework using an ABD to ABCD to ABCDE ring strategy, 
with a single ABC to ABCDE strategy known in the literature.1  
 
1.3.1.1 Convergent ABD to ABCD approaches 
 In 1998 Lounasmaa et al.11 published a stereoselective racemic total synthesis of 
tacamonine which involved a more efficient approach based on their prior work.5,6 In this 
approach they relied on the development of the D-ring component from a substituted 
pyridine and made use of epimerization to form the required cis D/E-ring junction. They 
began with the synthesis of ester intermediate 20 which was achieved over three steps 
(Scheme 2). This involved the alkylation of pyridine 17 with tryptophyl bromide, followed by 
catalytic Wenkert hydrogenation of 18 in the presence of base. Acid-induced cyclization of 
19 afforded the kinetically favoured trans D/E ester intermediate 20 as a single 
diastereomer. 
 
Scheme 2. The initial stages of the Lounasmaa group's approach, including epimerization for the 
formation of the cis D/E-ring junction.11 
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 Interestingly, the group found that treatment of 20 with sodium methoxide in 
methanol followed by reesterification in methanol saturated with hydrogen chloride led to 
the formation of products 22 and 23 in a 4:1 ratio. They postulated that this process occurs 
through the sodium salt intermediate 21, since the corresponding acid could be isolated, 
and rationalised that the C-14 proton could be exchanged with base leading to the more 
thermodynamically favourable epimer 22 with the original ethyl group now in the equatorial 
position (more on these conformational aspects later).    
 With ester 22 in hand, possessing the required all cis-H stereocentres, the final ring 
of the pentacyclic core could be constructed (Scheme 3). Reduction of ester 22 produced 
alcohol 24, which was then converted to nitrile 25 via the tosylate. Finally, consecutive acid 
and base treatments of nitrile 25 allowed for the two-step, one-pot conversion to racemic 
tacamonine (11) in high yield. 
 As a whole, the route involves 10 operations over 7 steps providing the target in 
23% overall yield, making it one of the more efficient racemic syntheses of tacamonine 
developed to date. The only drawback being the laborious one-carbon extension in the 
end-game for completing the E-ring.  
 
Scheme 3. The concluding steps in the stereoselective racemic total synthesis of tacamonine by 
Lounasmaa et al.11 
 A few years later a somewhat unique stereoselective but still racemic total synthesis 
was developed by Lavilla et al. and published in 2001.12 Unlike any of the other methods 
that follow in this discussion, the group used a non-biomimetic oxidative halocyclization of 
a 1,4-dihydropyridine for the formation of the C-ring following the same ABD to ABCD 
strategy. Furthermore, the group made use of radical addition of the resulting halo 
derivative to an activated alkene to install the requisite cis D/E-ring junction.  
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 Their approach (Scheme 4) began with the synthesis of the desired 1,4-
dihydropyridine 27 which was obtained through literature procedures involving 
quaternization of 3-acetylpyridine with tryptophyl bromide and concomitant reduction of the 
pyridinium salt with sodium dithionite (not shown).13 In a previous work,14 the group had 
shown that iodo derivative 29 could be obtained stereoselectively as a result of the non-
biomimetic oxidative halocyclization of 27 via 28 owing the more nucleophilic character of 
the enamine in contrast to the vinylogous amide. In addition, they found that radical Zn-
mediated conjugate addition of 29 and α-chloroacrylonitrile led to the formation of the cis 
indoloquinolizidine 30 as a mixture of C-16 epimers. This stereochemical outcome implied 
a clean inversion of configuration at the pro-radical centre leading to the 
thermodynamically more stable cis product. This result was supported by further 
theoretical calculations that suggested conformational control at the radical level leading to 
the preferred facial selectivity. The selective formation of the cis D/E-ring relieves steric 
strain between the bulky indole substituent in the pseudoequatorial position and the D-ring 
side chain in the axial position as depicted in 31.    
 
Scheme 4. Stereoselective racemic total synthesis of tacamonine by Lavilla et al.12 
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 Once the cis D/E-ring junction had been established the group moved on to prime 
the E-ring precursor for cyclization. Chloronitrile 30 was advanced to acetoxynitrile 32 as 
an epimeric mixture under phase-transfer catalysis (18-C-6) conditions. Further hydrolysis 
and spontaneous cyclization of the aldehyde product resulted in the formation a mixture of 
C-16 N,O-hemiacetal epimers which were immediately oxidized to yield acylindole 33. 
 The group then moved on to generate the C-20 stereocentre and establish the all 
cis-H framework. Pleasingly, they found that simultaneous reduction of the olefin and 
carbonyl moieties took place with stereocontrol via syn-addition from the least-hindered 
face to afford epimeric alcohol mixture 34, which was advanced to racemic tacamonine 
(11) following Barton-McCombie deoxygenation of the corresponding thioimidazolide. 
Though this route highlights several interesting aspects of stereocontrol and encompasses 
only 6 steps from 27 over 8 operations, it is unfortunately highly inefficient, boasting an 
overall yield of less than 1% from 27.   
 In 2008, Ho and co-workers reported another stereoselective racemic total 
synthesis of tacamonine.15 Conceptually, the group aimed to make use of a bridged D-ring 
precursor to direct the cis D/E-ring junction formation during the imine reduction stage of 
the Bischler-Napieralski cyclization. These efforts began with the synthesis of the requisite 
D-ring precursor (Scheme 5). Bridged 35, acquired through a literature acyloin 
condensation procedure (not shown),16 was subsequently oxidised to diketone 36. 
Stereoselective exo borohydride reduction and concomitant acetylation produced 37 which 
was then subjected to aggressive oxidative cleavage to afford diacid 38. 
 
Scheme 5. The Ho group's synthesis of D-ring precursor 38.15 
 With diacid 38 in hand, the stage was now set to attach the tryptamine moiety and 
assemble the desired bridged D-ring precursor, containing all the carbon atoms of the non-
tryptamine fragment (Scheme 6). This conversion to glutarimide 39 was carried out in a 
one-pot, two-step reaction procedure involving initial amide formation and subsequent ring 
closure. Glutarimide 39 was then advanced to lactam 41 through a series of functional 
group manipulations, namely, treatment with Lawesson's reagent to provide the monothio 
derivative 40 and subsequent reductive desulfurization with Raney nickel.  
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 At this point the C-ring was assembled under Bischler-Napieralski conditions and 
advanced to diol 42 by global reduction of the iminium salt and acetyl groups. The 
observed cis stereoselectivity was rationalised on steric and stereoelectronic grounds in 
favour of hydride attack from the -face of a bridge-locked iminium salt as previously 
anticipated.  
 
Scheme 6. Completion of the racemic total synthesis of tacamonine by Ho et al.15 
 Moving on to the E-ring assembly, oxidative periodate cleavage of the vicinal diol in 
42 proceeded with spontaneous cyclization to afford a mixture of unstable epimeric N,O-
hemiacetals which were immediately oxidised to lactam aldehyde 43. Finally, 
deoxygenation of the remaining formyl group via its ethylenedithioacetal afforded racemic 
tacamonine (11) in 7% overall yield from 35 in 10 steps over 14 operations. Though this 
synthesis embraced some elegant chemical manipulations, it is unfortunately rather 
lengthy as a result. 
 
1.3.1.2 Linear D-ring construction strategies 
 As is evident from the discussion of these more classical approaches, in general we 
see that the D-ring fragment is constructed prior to the addition of the tryptamine fragment 
in a convergent approach to furnish an ABD construct. In more recent years, various 
approaches have emerged that allow for the construction of the D-ring in the presence of 
the tryptamine fragment as part of a more linear approach, while still falling under the 
general ABD to ABCD ring-construction strategy.  
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 One such method was published by Chen et al. in 2003, thereby securing a formal, 
entry towards the synthesis of racemic tacamonine.17 Their investigations centred on the 
use of a regioselective reduction for the conversion of an N-alkyl-3-sulfonyl glutarimide, 
generated through their previously developed [3 + 3] annulation strategy,18 into a lactam. 
In this work (Scheme 7), they envisaged target 47 as a product of this new procedure and 
rationalised that it could be converted to lactam 48, which could subsequently be 
converted to racemic tacamonine (11) according to literature precedents.19 Indeed, they 
established that reaction of Baylis-Hillman adduct 45 with the appropriate 
sulfonylacetamide 44 afforded target 46 in a one-pot stepwise [3 + 3] annulation process 
using sodium hydride as a base promoter.  
 
Scheme 7. Formal non-stereoselective racemic synthesis of tacamonine by Chen et al.17 
 The mechanism of this reaction was postulated to proceed through 1,4-Michael 
addition, intramolecular cyclization and elimination as depicted in Scheme 8.   
 
Scheme 8. The Ho group's proposed mechanism for the [3 + 3] annulation strategy.17 
 In the subsequent step (Scheme 7) glutarimide 46 was selectively reduced at the 
more electrophilic carbonyl group (due to the electron-withdrawing sulfonyl group invoking 
a greater resonance stabilisation by nitrogen of its adjacent carbonyl) to yield lactam 47. 
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 Subsequent reductive desulfonation afforded 48, thus constituting a non-
stereoselective racemic formal entry via literature procedures.19           
 In 2005, Ihara et al. developed another non-stereoselective racemic formal entry via 
a linear ABD to ABCD strategy through application of their newly developed intermolecular 
tandem aza-Michael/C-Michael procedure.20 Using this methodology21 (Scheme 9), the 
group was able to furnish piperidinone 50 in high yield through the intermolecular 
dimerization reaction of acrylamide 49 using tert-butyldimethylsilyl triflate as a Lewis acid 
promoter, followed by global N-Boc protection of the product. This intermolecular reaction 
presumably proceeds via azaenol silyl ether formation (of the secondary amide) of one of 
the partners, followed by aza-Michael addition on to the other, thereby setting up a closure 
opportunity via a C-Michael. In the subsequent step, treatment of 50 with sodium 
methoxide resulted in the simultaneous removal of the N-Boc indole group to afford methyl 
ester 51. Finally, selective reduction of the ester with lithium borohydride afforded target 
alcohol 52 which has been previously converted to tacamonine in the literature19 via 
lactam 48 as with the Chen group's synthesis previously. 
 
Scheme 9. Formal non-stereoselective racemic synthesis of tacamonine by Ihara et al.20 
 In 2006, Deiters et al. also reported a linear strategy for the formation of the D-ring, 
which was achieved through a ring-closing metathesis/1,4-addition process in order to 
achieve the usual ABD to ABCD strategy (Scheme 10).22  
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 Their efforts began with the EDCI-mediated amide coupling between readily 
available 53 and diallylamine to form the desired metathesis substrate 54. Their novel one-
pot, two-step procedure transformed 54 into 56 via sequential ring-closing metathesis and 
zirconocene-catalyzed carbomagnesium reactions.  
 
Scheme 10. Formal non-stereoselective racemic synthesis of tacamonine by Deiters et al.22 
 The postulated mechanism of this fascinating organometallic reaction from 55 to 56 
(Scheme 11), investigated by Hoveyda et al. in similar works,23,24 proceeds via the initial 
formation of zirconocene (61) followed by insertion of the alkene 55 to give 62. 
Subsequent cleavage of the zirconacyclopentane by ethylmagnesium bromide via 63 and 
64 results in the formation of 56 as depicted in Scheme 11. 
 In the remaining steps (Scheme 10), reduction of the amide group in 56 and 
treatment with acryloyl chloride to introduce the requisite side chain afforded 58, thereby 
installing the fragments necessary for the second ring-closing metathesis step. Indeed, the 
D-ring was generated smoothly when subjected to metathesis conditions. In the final 
operations, 59 was subjected to catalytic hydrogenation and elaborated via the familiar 
Bischler-Napieralski cyclization. This process led selectively to 60, which had already been 
reported as an advanced intermediate, thus constituting a formal racemic synthesis of 
tacamonine via the method of Ihara et al.8 
14 
 
 
Scheme 11. Postulated mechanism of the zirconocene-catalyzed carbomagnesium reaction.23,24 
 Certainly one of the more innovative approaches to the pentacyclic tacaman 
skeleton was reported by Padwa et al. in 2008.1 Their approach differs to the more 
conventional methods previously discussed as the C-ring is assembled prior to the D-ring 
in an ABC to ABCDE strategy, in which the D- and E-rings are constructed simultaneously 
through a novel Rh(II)-catalyzed cyclization/cycloaddition cascade.  
 More specifically (Scheme 12), these efforts commenced through treatment of 
carboline 65 with the associated acid chloride to form 66, which was then advanced to 
cycloaddition precursor 67 via indole N-acylation with ethyl 2-diazomalonyl chloride using 
sodium hydride to generate the anion. They postulated that heating 67 with a catalytic 
amount of rhodium(II) acetate would generate a rhodium carbenoid intermediate that 
would react with the lactam carbonyl to generate an oxonium-ion ylide intermediate 68, 
which in turn would react in an intramolecular 1,3-dipolar cycloaddition. Pleasingly, they 
found that subjecting α-diazoindoloamide 67 to their Rh(II) cascade conditions gave the 
desired intramolecular [4 + 2] cycloadduct 69 in high yield and as a single diastereomer, 
the latter due to the tight stereocontrol operating in the cycloaddition step. 
 At this stage, bearing in mind the need to generate an all cis-H stereochemical 
requirement between H-3/14 and H-20 ultimately, they envisioned a catalytic enamine 
hydrogenation strategy to deliver the desired D/E-ring junction resulting from syn-addition 
from the least hindered face. 
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Scheme 12. Stereoselective racemic total synthesis of tacamonine by Padwa et al.1 
  To this end, enamine 70 was synthesized via oxabicyclic eliminative ring opening 
with boron trifluoride diethyl etherate from 69 in high yield. With the enamine in place, 
catalytic hydrogenation of 70 forged the requisite cis-fused ring system as a single 
diastereomer 71, as anticipated. 
 Thereafter, the group focused on the preparation of the six-membered E-ring, which 
they envisaged as accessible through ring-contraction of a keto-amide. In this process, 
removal of the carbethoxy group was achieved following decarboxylation of 71 with 
magnesium iodide to afford a secondary alcohol which was immediately oxidized to the 
requisite keto-amide 72. Further advancement to hydroxy ester 73 as a mixture of C-16 
diastereomers was achieved under base-induced ring-contraction conditions. With the 
tacaman framework now firmly in place, global reduction of both the ester and lactam 
carbonyl functionalities was achieved through treatment of 73 with excess lithium 
aluminium hydride to deliver the diol, which was then immediately subjected to sodium 
periodate oxidative cleavage to yield racemic tacamonine (11) as a single diastereomer in 
7% overall yield from 65 over 8 steps consisting of 10 total operations in an elegant 
synthesis, but one with an over-elaborate endgame. 
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 1.3.2 Asymmetric Total Syntheses of (+)-Tacamonine 
 Since its isolation in 1984, only two asymmetric total syntheses of (+)-tacamonine 
have emerged in the literature, the first of which was achieved by Ihara et al. in 1994.8 
These syntheses still rely on certain diastereoselective reaction steps, but generate only 
the (+)-enantiomer by beginning with a suitable chiral, non-racemic precursor. The Ihara 
group's approach (Scheme 13), was thus based on the synthesis of a chiral, non-racemic 
propane-1,3-diol intermediate 74 to install the requisite homochiral C-20 stereocentre, from 
which the other stereocentres were derived diastereoselectively. In terms of what has 
been described before, the synthesis pursued a linear AB to ABD strategy and in which 
radical cyclization was used as the key step. Thereafter, a Bischler-Napieralski cyclization 
was used to afford an ABCD intermediate, followed by consecutive reduction and E-ring 
closure processes. A retrosynthetic analysis of their synthesis is shown in Scheme 13. 
 
Scheme 13. Retrosynthetic analysis of the Ihara group's asymmetric approach.8 
 Thus, these efforts commenced with the synthesis and modification of the chiral 
precursor 74 shown in Scheme 14, in which readily available chiral oxazolidinone 75 was 
advanced to 76 through standard Evans methodology.25 Compound 76 was then 
diastereoselectively hydroxymethylated to 77 when subjected to titanium(IV) chloride, 
triethylamine and s-trioxane followed by protection of the hydroxyl group of the product. 
Though 77 was obtained in high diastereomeric excess, it was unfortunately synthesized 
in only 48% yield. Subsequent reductive auxiliary deprotection of 77 with lithium 
borohydride in the presence of one equivalent of water provided the desired chiral 
precursor 74 in high optical purity (~100% ee) and in good yield. Mesylation and 
concomitant bromination of 74 afforded the chiral bromo-intermediate 78 necessary for the 
ensuing tryptamine coupling step.   
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Scheme 14. Synthesis and modification of the chiral precursor 74 by Ihara et al.8 
 With 78 in hand, the group then sought to combine all of the required fragments 
together (Scheme 15). This was achieved through a simple SN2 substitution reaction of 
bromide 78 with tryptamine followed by DCC coupling of the product in the presence of 
DMAP with fumaric acid monoethyl ester to afford amide 79 in a fair 64% yield overall. In 
order to prepare the radical cyclization precursor 81, 79 was first subjected to deprotection 
conditions for the removal of the silyl group followed by mesylation and bromination of the 
product 80.  
 
Scheme 15. Completion of the first asymmetric total synthesis of (+)-tacamonine by 
Ihara et al.8 
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 The key step in this synthesis, involving the formation of the D-ring, was achieved 
through radical cyclization of 81 using tris(trimethylsilyl)silane in the presence of AIBN, 
which proceeded via a 6-exo-trig stereomode to afford product 82. However, this was 
obtained in a suboptimal yield and unfortunately as a 1:1 mixture of diastereomers (relative 
to C-20) which were carried over into the remaining steps. 
 With advanced intermediate 82 in hand, the synthesis was completed in a three-
step procedure through Bischler-Napieralski C-ring formation, reduction of the product in 
the presence of the ester with sodium cyanoborohydride, and finally, E-ring formation 
through nucleophilic acyl substitution with sodium methoxide. These concluding steps 
resulted in the formation of the target 11 as a diastereoisomeric mixture from which the 
correct all cis-H diastereomer was isolated in a meagre 9% yield.  
 In summary, the group was able to synthesize (+)-tacamonine in only 1% overall 
yield from oxazolidinone 75 involving a total of 15 operations over 9 distinct steps. 
Although asymmetric, this synthesis was highly inefficient and produced tacamonine as a 
diastereoisomeric mixture from which the correct all cis-H diastereomer 11 had to be 
isolated in the final step.  
 In 2001, Danieli and co-workers published the only other asymmetric total synthesis 
of (+)-tacamonine known in the literature, this time avoiding the task of tedious 
diastereoisomeric separation in the final step.9 The key disconnections in their approach 
were similar to those of the Ihara group (Scheme 13), following an ABD to ABCD to 
ABCDE ring construction strategy, also involving a linear D-ring construction. Their work 
relied on the use of an optically pure 2-substituted propane-1,3-diol intermediate which 
was in this case obtained through selective enzymatic acylation of an enantiotopic group 
instead of using a chiral auxiliary approach. Furthermore, similar to the previously 
mentioned strategy of the Padwa group (Scheme 12), a stereocontrolled reduction 
procedure was utilized in order to generate the requisite D/E-ring junction. 
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 The group began with readily available tosyloxybutyne 83 which was advanced to 
diol 84 through standard procedures (Scheme 16). In the following step, desymmetrization 
of diol 84 was achieved via enzymatic PPL transesterification providing monoacetate 85 in 
good yield and in high enantiomeric excess (98% yield, >99% ee). Subsequent 
ozonization of 85 afforded chiral lactone 86 in high 97% yield as desired.   
 
Scheme 16. Synthesis of the chiral precursor 86 by Danieli et al.9 
 With chiral lactone intermediate 86 in hand, the group was able to couple with the 
tryptamine fragment through chemoselective nucleophilic acyl substitution producing 
alcohol 87 in a good 76% yield (Scheme 17). The D-ring component was then formed in 
two further steps involving mesylate formation to afford 88, followed by cyclization under 
basic conditions to give the desired cyclization product 89. Lactam 89 was then easily 
converted to enamine 90 under standard Bischler-Napieralski conditions. 
 
Scheme 17. Coupling of the tryptamine fragment and C-ring formation by Danieli et al.9 
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 Through prior experience the group was aware that enamines such as 90 could be 
advanced to pentacyclic compounds embodying an oxazepinoindoloquinolizine skeleton 
(91, Scheme 18) through reaction with formaldehyde followed by sodium borohydride. 
 
Scheme 18. Completion of the final known asymmetric total synthesis of (+)-tacamonine 
by Danieli et al.9 
 In the event, successful formation of pentacycle 91 still containing the C-3/C-14 
double bond set the stage for the diastereoselective addition of hydrogen, on the basis that 
approach from the concave α-face of the molecule would be severely hindered by the 
pseudoaxial oriented C-20 group, as before. This process afforded 92 in high 
diastereomeric excess (9.5:1 dr) and in satisfactory yield (75%). Subsequent homologation 
of the C-20 acetoxymethyl side chain in 92 was achieved in a three-step sequence 
involving acetate hydrolysis, tosylation and displacement of the tosylate with lithium 
dimethyl cuprate (54% over 3 steps) to afford 93. In the penultimate operation the group 
employed Sundberg's deprotection protocol to form alcohol 94, which was followed by the 
concluding E-ring formation according to the Lounasmaa group's procedure11 in 
suboptimal yields of 61% and 48% respectively.  
 Overall, the route encompasses a lengthy 17 operations over 15 steps from 
commercially available starting materials, providing enantiopure (+)-tacamonine (11) in 
only 4% overall yield.   
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1.4 Conclusions 
 As is evident from the discussion of these two reported asymmetric routes, there is 
much room for improvement in terms of the overall number of steps, as well as the 
efficiency of these steps, since the Ihara and Danieli groups were able to synthesise (+)-
tacamonine in only 1% and 4% overall yields respectively from readily available starting 
materials.8,9 Though the Ihara group's strategy proceeded over a reasonable 9 steps in 
comparison to the Danieli group's lengthy 15 step route, the major drawback was the lack 
of diastereoselectivity in the radical cyclization which ultimately had a significant impact on 
the overall yield and efficiency of the route as a whole. 
 Furthermore, these asymmetric routes both followed the standard linear ABD to 
ABCD ring-construction strategy beginning with a chiral, non-racemic precursor, obtained 
via chiral auxiliary-based methodology in the Ihara group, and enzymatic monoacetylation 
in the case of the Danieli group. In both cases this allowed for the pre-installation of the 
requisite homochiral C-20 stereocentre, from which the other stereocentres were 
successfully derived diastereoselectively by the Danieli group.  
 In view of these reports, we aimed to develop a concise, efficient, asymmetric total 
synthesis strategy following a novel ABC to ABCD approach, the full extent of which will be 
presented and discussed in Chapter 2.  
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Results and Discussion 
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2.1 Background 
2.1.1 Introduction  
 Natural (+)-tacamonine has been a long-standing synthetic target in our laboratory, 
with initial studies dating as far back as 1997.1 These model studies, which will be 
discussed in detail shortly, were based on the generation of the tacaman skeleton through 
cyclization of an α-acylamino radical.1-3 The aim of this work was thus to extend this 
methodology to a modified system in order to complete an asymmetric total synthesis of 
(+)-tacamonine (1, Figure 1). 
 
Figure 1. A depiction of the natural (+)-tacamonine numbering convention used in the literature.4 
 When considering the structure of (+)-tacamonine (1, Figure 1), the two significant 
synthetic challenges that needed to be addressed, in addition to the construction of the 
pentacyclic core itself, were the control of both the C-3/C-14 D/E cis-ring junction 
diastereoselectivity as well as the C/D to C-20 (ethyl) anti-diastereoselectivity, since all the 
C-3, C-14, and C-20 methine hydrogens had to be positioned cis relative to each other. 
Our approach to these intricate synthetic challenges will be discussed later on. At this 
stage, however, it should be noted that all the structures presented in this chapter are 
numbered relative to the natural (+)-tacamonine numbering convention as shown in Figure 
1 (ring designations A to E also shown).4         
 
2.1.2 Previous Work: Stereoselective Model D-Ring Construction Strategies 
 In 1997 our group developed a moderately stereoselective benzylic α-acylamino 
radical cyclization strategy for addressing the chemistry of generating the tacaman D/E-
ring junction, in which a phthalimide template was used to model the ABC ring system.1 In 
this (Scheme 1), it was found that cyclization of the ribose-derived 2 could be achieved 
under normal radical cyclization conditions (via radical intermediate 3) leading 
predominantly to the undesired trans-H C-3/C-14 junction in 4 in a 4:1 diastereomeric ratio. 
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Scheme 1. Reagents and conditions: Bu3SnH (1.5 equiv), AIBN (0.1 equiv), benzene, 
reflux, 4 h, 56%, dr = 4:1.  
 Although it gave the wrong target D/E ring-junction relative stereochemistry, as well 
as having a five-membered modelling for the C-ring, nevertheless, it suggested that a 
benzylic radical could be generated and utilised for the purpose of forming the target’s C3-
C14 D/E bond, as well as suggesting that an adjacent allylic centre to C-14 might be able 
to satisfactorily direct the diastereoselectivity of ring junction formation.  
 This notion was tested in a subsequent 2000 work (Scheme 2), where a modified 
precursor 5 derived from (S)-malic acid was subjected to the same radical cyclization 
conditions.2 This led to the formation of the desired major cis-H diastereomer 6 in a 4:2:1 
diastereomeric ratio following silyl group removal, providing support in favour of directing 
the diastereoselectivity, this time through the use of a bulky silyloxy group at the allylic 
position to achieve the correct cis-D/E-diastereoselectivity. 
 
Scheme 2. Reagents and conditions: (i) Bu3SnH (3 equiv), AIBN (0.1 equiv), PhMe, reflux; (ii) 
TBAF, THF, 55% (as major diastereomer, over 2 steps), dr = 4:2:1.  
 In a more recent work published in 2009, the same radical cyclization methodology 
was applied to a substrate more closely related to the tacaman skeleton; namely, that of 2-
acyl-1-phenyl-thiotetrahydro--carboline (9, Scheme 3).3 This model precursor 9 was 
synthesized through N-acylation/iminium ion trapping of an acid (7) and 3,4-dihydro--
carboline (8) under mild conditions, designed to accommodate sensitive acids bearing α-
stereocentres (as is the case of the target).  
 It was found that this could be achieved in one-pot through initial DCC/HOBt-
activation of the acid 7 followed by N-acylation with the highly nucleophilic -carboline 8. 
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Concomitant low-temperature boron trifluoride diethyl etherate-mediated interception of the 
resultant iminium ion with thiophenol provided 9 in high yield. 
 
Scheme 3. Reagents and conditions: (i) 7 (1.2 equiv), DCC (1.2 equiv), HOBt (1.2 equiv),CH2Cl2, 0 
°C; (ii) 3,4-dihydro--carboline (1.0 equiv); (iii) PhSH (1.3 equiv), BF3·OEt2 (1.3 equiv), –78 °C, 
88% (one-pot); (iv) Boc2O (1.3 equiv), DMAP (0.1 equiv), THF, rt, 98%.   
 Subsequent indole N-Boc protection afforded the requisite precursor 10, which was 
then subjected to the standard radical cyclization conditions (Scheme 4). Much to our 
group's delight, the desired cis-H diastereomer 11 was formed as the major product in 
81% yield in addition to the minor trans-H diastereomer 12 and radical reduction product 
13 in 12% and 6% yields respectively (dr = 6.5:1), 11 and 12 both as racemic products.     
 
Scheme 4. Reagents and conditions: Bu3SnH (1.5 equiv), ACCN (0.1 equiv), PhMe, reflux, 81% 
(11), 12% (12), 6% (13), dr = 6.5:1. 
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 Further evidence for the formation of the desired cis-H diastereomer was provided 
in the form of an X-ray crystal structure determination. To this end, major lactam 11 
(isolated as a gum) was subjected to standard saponification conditions to afford the 
crystalline acid. The X-ray structure of the acid 14 obtained (shown in Figure 2) clearly 
confirmed the desired cis arrangement of H-3 and H-14.  
 
Figure 2. X-ray crystal structure of acid 14 displaying the correct cis arrangement of H-3 and H-14 
by Smith et al.3 
 The proposed transition states for the formation of the cis-H (11) and trans-H (12) 
products are shown in Figure 3 as TS-1 and TS-2 respectively. In this model, which was 
based on the assumption that the larger indole substituent adopts a pseudoequatorial 
position, TS-1 showed that the cis-H product would arise from the enoate ester adopting a 
pseudoaxial orientation, while in TS-2, the ester in a pseudoequatorial orientation would 
afford the trans-H product. In the case of the latter, non-bonded steric interaction of the 
ester with the bulky N-tert-butoxycarbonyl group causes significant destabilization, thus 
favouring the formation of the cis product. 
 
Figure 3. Proposed transition state model for the observed stereoselectivity (X = CO2Et) by 
Smith et al.3 
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 This encouraging result in favour of the generation of the cis-H (D/E) diastereomer 
propelled us to attempt the radical cyclization on the tacamonine precursor itself, with the 
C-20 ethyl group already in place, in the hope of achieving the correct C-3/14 to C-20 
diastereoselectivity.   
 
2.1.3 Retrosynthetic Analysis of (+)-Tacamonine        
 Our approach using this radical cyclization disconnection strategy is thus outlined 
retrosynthetically in Scheme 5. In the forward sense, using coupling methodology shown in 
Scheme 3, we envisaged the synthesis of the radical cyclization precursor 17 through 
coupling/trapping of a chiral acid ester fragment (15) and 3,4-dihydro--carboline (8) 
followed by N-Boc protection. We postulated that concomitant radical cyclization should 
then result in the stereoselective formation of the desired all cis-H diastereomer 18. 
Additionally, the initial end-game strategy perceived for the subsequent conversion of the 
cyclization product 18 to (+)-tacamonine (1) involved N-Boc deprotection, base-mediated 
E-ring formation and chemoselective reduction processes respectively.       
 
Scheme 5. Our retrosynthetic analysis of (+)-tacamonine. 
 Our retrosynthetic approaches to each of the identified coupling fragments 15 and 8 
are in turn shown in Scheme 6. In the forward sense, we envisaged the synthesis of the 
chiral acid ester fragment 15 through diastereoselective auxiliary-controlled allylation 
followed by auxiliary cleavage and attachment of the ester moiety via olefin metathesis. In 
the case of the carboline fragment 8, we envisaged N-formylation of tryptamine and 
subsequent Bischler-Napieralski cyclization of the product.      
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Scheme 6. Retrosynthetic analysis of the acid ester (15) and carboline (8) fragments respectively. 
 Naturally, we expected various challenges to arise along the way, particularly in the 
case of the radical cyclization step, although we believed that the same controlling factors 
would hold leading to the required D/E stereoselectivity as for the model (Figure 3). What 
was not apparent, however, was the question of the anti C-3/C-14 (D/E) to C-20 
diastereoselectivity, that is, to obtain the D/E-ring junction as having the hydrogens both 
'up' in absolute stereochemical terms, as in (+)-tacamonine (1, Scheme 5 for numbering). 
Before carrying out the synthesis it is true to say that we did not have any firm mechanistic 
basis for confidently believing that the radical cyclization would result in achieving this 
stereo-outcome, other than the fact that generating a cis D/E-ring junction with the 
hydrogens 'up' would secure a pseudoequatorial configuration for the C-20 'down' ethyl 
group (see later). Similarly, a level of concern existed for achieving an appropriate 
chemical efficiency in the final chemoselective reduction.  
 A discussion of our results now follows, and any modifications made to the initial 
strategy and justifications thereof will be presented.  
 
2.2     Asymmetric Total Synthesis of (+)-Tacamonine 
2.2.1 Synthesis of the Chiral Acid Ester and Carboline Fragments 
 We began our asymmetric total synthesis of (+)-tacamonine by first synthesizing 
each of the previously identified coupling fragments, namely, 3,4-dihydro--carboline (8) 
and the chiral acid ester 15.  
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 In the case of the former, the procedure of Whittaker5 was adopted in a classical 
Bischler-Napieralski reaction as shown in Scheme 7, proceeding via an electrophilic 
aromatic substitution based cyclization involving an iminium species (not shown). 
 
Scheme 7. Reagents and conditions: (i) ethyl formate (excess), 70 °C, 17 h; (ii) POCl3 (excess), 0 
°C to rt, 1.5 h, 96% (over 2 steps). 
 To that end, a suspension of tryptamine in excess ethyl formate was heated 
overnight and left to cool to room temperature after 17 h. The remaining ethyl formate was 
then removed in vacuo to afford crude N-formyltryptamine 24 as a brown oil,6 which was 
immediately used in the next step without further purification. Advancement to 3,4-dihydro-
-carboline was achieved through treatment of 24 with excess phosphoryl chloride at 0 °C, 
followed by stirring at room temperature. After 1.5 h excess phosphoryl chloride was 
removed by distillation. The target carboline fragment 8 was then isolated in 96% crude 
yield over two steps in gram quantities (~10 g scale) following quenching with water and 
basic work-up. 1H NMR spectroscopy of the resulting crude pale yellow micro-crystalline 
product showed all the characteristic peaks along with line broadening as a result of 3,4-
dihydro--carboline existing in equilibrium with its dimeric form.7 The 1H NMR spectral and 
melting point data obtained were in agreement with the literature,5,6 which indicated that 
the crude material could be used without further purification. 
 With 3,4-dihydro--carboline in hand we focused our efforts toward the synthesis of 
chiral acid ester fragment 15. Using the method of Evans8 (Scheme 8), (S)-4-benzyl-2-
oxazolidinone 20 (~1 g scale) was treated with n-butyllithium at low temperature followed 
by the addition of butyryl chloride after 30 min and allowing the solution to warm to room 
temperature. TLC analysis showed the clean conversion of the starting material to a less 
polar spot as expected. After 4 h the solution was quenched, extracted and purified by 
flash chromatography to afford the known butylated oxazolidinone 21 in 98% yield and in 
high enantiomeric excess (98%) as ascertained by chiral HPLC on a chiral OD column. 
The 1H NMR, 13C, IR, HRMS and optical rotation data of 21 were all in agreement with the 
literature data (see Chapter 3 section 3.1).8,9 
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Scheme 8. Reagents and conditions: (i) n-BuLi (1.1 equiv), THF, –78 °C, 30 min; (ii) butyryl 
chloride (1.4 equiv), –78 °C to rt, 4 h, 98%, 98% ee; (iii) NaHMDS (1.1 equiv), THF, –78 °C, 30 
min; (iv) allyl bromide (2.5 equiv), –78 °C to –20 °C, 5 h, 86%, dr = 98:2.     
 In the following step, oxazolidinone 21 (~1 g scale) was treated with sodium 
hexamethyldisilazide at –78 °C to allow for the formation of the (Z)-kinetic enolate as 
depicted in Scheme 8 as 25, followed by the addition of allyl bromide after 30 min. The 
reaction mixture was then left to warm slowly to –20 °C over 5 h after which it was 
quenched, extracted and purified by flash chromatography to afford the known allylated 
oxazolidinone 22 in 86% yield and in a diastereomeric ratio of 98:2 as ascertained by 
HPLC on a C-18 column. The diastereoselectivity manifested in this step is as a result of 
steric blockage of re facial approach of the electrophile by the chiral auxiliary, which is 
locked in place through sodium ion chelation, all in accordance with the model proposed 
by Evans in his original work.10 Furthermore, full characterization data obtained was once 
again in complete agreement with the literature data for 22.11 
 Advancement to the desired chiral acid ester fragment 15 was achieved in two 
further steps, involving auxiliary cleavage and olefin metathesis (Scheme 9). In the case of 
the former, allylated auxiliary 22 (~1 g scale) was treated with lithium hydroperoxide at 0 
°C for 2 h for the chemoselective hydrolysis of the exocyclic carbonyl group, followed by 
the addition of sodium sulfite for the reduction of the peracid intermediate and the 
consumption of unreacted lithium hydroperoxide.12 TLC analysis showed the clean 
conversion of the non-polar starting material to the characteristic polar acid spot. A 
subsequent extraction process allowed for 96% recovery of the chiral auxiliary. Further 
acidification, re-extraction and concentration in vacuo processes afforded crude acid 23 in 
quantitative yield and in high purity.  
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Scheme 9. Reagents and conditions: (i) LiOH·H2O (2 equiv), H2O2 (5 equiv), Na2SO3, THF/H2O, 0 
°C, 2 h, 100% (crude yield), 96% (auxiliary recovery); (ii) ethyl acrylate (5 equiv), Hoveyda-Grubbs 
2nd generation cat. (0.01 equiv), CH2Cl2, rt to 50 °C, 2 h, 96%, 96% ee.  
 This auxiliary cleavage procedure, pioneered by Evans, was selected as it is known 
to allow for the chemoselective detachment of the exocyclic carbonyl group without 
racemization of the newly installed chiral centre at C-20.12 It thus allowed for the swift 
formation of the desired chiral acid 23 under mild conditions at low temperature with no 
further purification deemed necessary. 
The 1H NMR spectrum of the chiral acid 23 obtained contained all the requisite peaks as 
shown in Figure 4, most notably the newly installed vinyl system (H-14/H-17).  
 
Figure 4. Crude 1H NMR spectrum of chiral acid 23. 
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 The H-14 signal was seen resonating at 5.77 ppm as well as the H-17 protons 
which were each seen as a doublet of doublets resonating at 5.09 and 5.04 ppm 
respectively with the appropriate geminal (1.7 Hz), cis-vinyl (10.1 Hz) and trans-vinyl (17.0 
Hz) couplings. The H-20 proton was observed as a single multiplet resonating at 2.21 ppm 
along with the diastereotopic and hence magnetically non-equivalent H-19 protons seen as 
two multiplets at 1.66 and 1.59 ppm respectively.          
 In the concluding operation (Scheme 9), acid 23 (~1 g scale) was subjected to olefin 
metathesis conditions involving reflux with excess ethyl acrylate in the presence of the 
Hoveyda-Grubbs 2nd generation catalyst for 2 h. This catalyst, in particular, was selected 
as it is known to favour the generation of the trans-alkene product in accordance with our 
target requirements.13 Following subsequent cooling, concentration in vacuo and 
purification by flash chromatography the desired acid ester fragment 15 was isolated in 
high 96% yield. Chiral HPLC analysis on an IC column verified that the loss of optical 
purity over these two steps was minimal as the enantiomeric excess remained virtually 
unchanged (98% to 96% ee), thus confirming that negligible racemization had occurred in 
the auxiliary cleavage process, as expected. Furthermore, our somewhat unusual decision 
to process the acid 23 itself in this way, instead of making use of any other potential 
surrogate group, was due to the need for chemoselectivity differentiation in the ensuing 
coupling step with the ester group already in place.   
  The 1H NMR spectrum of the acid ester fragment 15 (Figure 5) revealed the 
appearance of the newly installed ethoxycarbonyl group. Evidence for the formation of the 
trans-alkene was provided by the H-17 signal, which was now seen as a doublet at 5.87 
ppm, with an appropriate trans-vicinal coupling of 15.6 Hz. Similarly, the 13C NMR 
spectrum (Figure 5) showed the presence of the downfield acid carbonyl group (C-21) at 
180.7 ppm as well as the newly installed ester carbonyl group (C-16) at 166.5 ppm. The 
vinyl carbon signals were seen at 145.4 and 123.6 ppm respectively, with the C-14 signal 
more deshielded than the C-17 signal as expected due to resonance considerations. The 
tertiary C-20 signal appeared at 60.5 ppm, followed by the two secondary C-15 and C-19 
carbon signals appearing at 33.7 and 24.8 ppm respectively (C-15 is deshielded relative to 
C-19 due to being allylic to the vinylic carbethoxy system). The secondary and primary 
carbon signals of the ethoxy group appeared at 45.7 and 14.4 ppm and are highlighted in 
Figure 5. Finally, the primary C-18 signal was seen at 11.5 ppm and was shielded relative 
to the primary ethoxy carbon as expected. Overall, a total of 10 carbon resonances were 
seen in the spectrum corresponding to all 10 carbon atoms in the acid ester structure. 
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Other evidence in support of the formation of the acid ester fragment 15 was obtained in 
the form of HRMS.       
 
 
Figure 5. 1H (top) and 13C (bottom) NMR spectrum of the acid ester fragment 15. 
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2.2.2 Synthesis of the Radical Cyclization Precursor          
 At this stage, with both the requisite carboline 8 and acid ester 15 fragments in 
hand, we envisaged the formation of the desired radical precursor 17 through our one-pot 
DCC coupling/thiophenol trapping sequence, followed by indole N-Boc protection of the 
product.3 There are recent alternatives for this type of coupling such as propylphosphonic 
anhydride14 (T3P, Figure 6), but we elected to go ahead with our method. 
 
Figure 6. Alternative amide coupling reagent T3P. 
 To this end (Scheme 10), acid ester 15 was cooled to 0 °C and treated with N,N'-
dicyclohexylcarbodiimide, 1-hydroxybenzotriazole and 3,4-dihydro--carboline (8) with 
stirring for 1 h. During this time TLC analysis showed a full conversion of the starting 
material to more polar spots as expected. The reaction mixture was then cooled to –78 °C 
followed by the addition of boron trifluoride diethyl etherate and then thiophenol, and the 
mixture left to warm slowly to –50 °C over a 1 h period; TLC analysis now indicating the 
conversion to two less polar spots. Following subsequent quenching, multiple extraction 
and filtration processes (for the removal of the urea by-product), and purification by flash 
chromatography, the desired sulfanyl amides 16 were isolated in 91% yield as a mixture of 
two diastereomers, with two amide rotamers each (see NMR analysis later). The 
scrambling at the sulfanyl C-3 stereocentre diastereomers was seen to be inconsequential 
at this stage since its stereogenicity would be lost upon formation of the radical species in 
the ensuing cyclization step. 
 
Scheme 10. Reagents and conditions: (i) DCC (1.1 equiv), HOBt (1.1 equiv), 3,4-dihydro--
carboline (1.2 equiv), CH2Cl2, 0 °C, 1 h; (ii) BF3·OEt2 (1.3 equiv), PhSH (1.3 equiv), –78 °C to –50 
°C, 1 h, 91%. 
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 The postulated mechanism of this one-pot N-acylation/iminium ion trapping 
procedure is shown in Scheme 11.  
 
Scheme 11. Mechanism of the N-acylation/iminium ion trapping of acid ester 15 and 3,4-dihydro--
carboline (8). 
 The first step involves the reaction of the acid ester 15 and N,N'-
dicyclohexylcarbodiimide to form the O-acylurea 26. 1-Hydroxybenzotriazole then 
substitutes O-acylurea 26 to give the BtO-active ester 27 and the dicyclohexylurea by-
product. The presence of the BtO group enhances the reactivity of the activated ester by 
encouraging/stabilising the approach of 3,4-dihydro--carboline in the following step via 
hydrogen bonding,15 which acylates to form the iminium ion, which presumably then gets 
intercepted by the BtO leaving group to form -alkoxy amide 28. Subsequent boron 
trifluoride diethyl etherate-mediated elimination via an SN1 dissociative process promotes 
dissociative cleavage back to the iminium ion 29, which then adds thiophenol to form the 
much more stable -sulfanyl amides 16. 
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 For purposes of the NMR discussion that follows it should be noted that both the 1H 
and 13C NMR spectra obtained for the sulfanyl amides 16 have been divided into two parts 
due to their complex nature. The 1H NMR spectrum is shown over the 0 to 5 ppm range in 
Figure 8 while the 5 to 9 ppm range is shown in Figure 9. Similarly, the 13C spectrum is 
shown over the 0 to 75 ppm and 100 to 180 ppm ranges in Figure 10 respectively. 
Moreover, the peaks belonging to the ethoxycarbonyl system have from this point onwards 
been labelled as 'OEt' for simplicity. Finally, these spectra would have been impossible to 
assign without the assistance of COSY (not shown) and HSQC analysis. In view of this, 
the corresponding HSQC data is shown below the 1H NMR spectra in Figures 8 and 9. 
 The 1H NMR spectrum of the sulfanyl amides 16 (Figure 8, Figure 9) revealed the 
appearance of 4 signals for each magnetically equivalent aliphatic and vinyl proton 
environment due to the presence of 2 diastereomers with 2 amide rotamers each as 
shown in Figure 7. They were found to exist in an 8:6:3:2 ratio, as estimated by 1H NMR, 
and have been grouped together for assignment purposes since the assignment of all the 
individual peaks for each diastereomer and each amide rotamer was beyond the scope of 
this work. Furthermore, integration of the individual peaks have been omitted for simplicity.    
 
Figure 7. A depiction of the amide rotamers and diastereomers present in the NMR spectra of the 
sulfanyl amide 16. 
  
39 
 
 Analysis of the 1H NMR spectrum for the 0 to 5 ppm range (Figure 8) revealed four 
distinct triplets resonating in the 0.7 ppm range corresponding to the magnetically 
equivalent H-18 protons (Me of the Et group). Similarly, four triplets (two overlapping) were 
seen in the 1.2 ppm range for the protons attached to the primary carbon of the ethoxy 
group and were deshielded relative to the H-18 signals as expected. The diastereotopic 
and thus magnetically non-equivalent H-19 protons were similarly seen as four multiplets 
in the 1.5 ppm region while the diastereotopic H-15 protons were deshielded resonating in 
the 2.3 ppm region as expected. The H-20 proton was observed as four multiplets, with 
two overlapping at 2.21 and 2.78 ppm respectively, while the H-6 protons were seen 
overlapping at 2.82 ppm. The proton signals for the secondary carbon of the ethoxy group 
were dispersed over 3.22 to 4.23 ppm. The H-5 protons were seen as four signals at 3.31, 
3.83, 4.09 and 4.92 ppm, interestingly displaying a large 1.61 ppm separation between the 
first and last signal.  
 In the remainder of the spectrum shown in Figure 9 (5-10 pm range), four distinct 
doublets for the H-17 proton of the vinyl system were seen resonating in the 5.7 ppm 
region while the vinyl H-14 signals were deshielded relative to H-17 in the 6.5 to 6.9 ppm 
range as expected, but also appearing as four distinct doublets. The H-3 proton was seen 
as four singlets at 6.34, 6.44, 7.38 and 7.42 ppm, once again displaying a significant 1.08 
ppm separation between the first and last signals similar to H-5. A possible explanation for 
this is that the s-cis amide rotamer has its carbonyl group deshielding zone facing towards 
H-3. A similar effect could thus be present for H-5 due to the close proximity of H-5 to the 
amide bond. Finally, the proton of the secondary amine was seen as four distinct singlets 
in the reasonable 8.2 ppm region. Aromatic protons were clumped as a range. 
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Figure 8. 1H NMR (top) and HSQC (bottom) spectra of the sulfanyl amides 16 shown over the 0 to 
5 ppm range. 
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Figure 9. 1H NMR (top) and HSQC (bottom) spectra of the sulfanyl amides 16 shown over the 5 to 
9 ppm range. 
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 Further observation of the 13C spectrum (Figure 10) once again showed 4 peaks for 
each magnetically equivalent aliphatic and vinyl carbon environment which were seen to 
overlap in some cases. The C-18, primary ethoxy carbon, C-19 and C-15 signals were all 
seen in regions similar to those in the 13C NMR spectrum of the acid ester precursor 15 
(Figure 5). The C-20 signals were shielded and appeared in the 42 ppm region while the 
secondary ethoxy carbon signals were deshielded and appeared in the 60 ppm region. 
The new C-6 resonances emerged around a reasonable 22 ppm, while the C-5 signals 
were once again seen to be separated over a 3.5 ppm range around 38 ppm. The vinyl (C-
17 and C-14) as well as the α,-unsaturated ester carbonyl resonances were all found in 
similar positions to those for the acid ester 15 (Figure 5). Finally, the newly formed amide 
carbonyl signals were found around 173 ppm and were shielded relative to the acid 
carbonyl resonance of the starting material, as expected.  
 At this stage it should be noted that the formation of the two amide rotamers in 
addition to the two diastereomers was also seen as inconsequential, since the amide bond 
was expected to interconvert between the s-cis and s-trans amide at the temperature of 
the ensuing radical cyclization (refluxing toluene, 110 °C).16 We postulated that this 
interconversion would therefore allow cyclization to complete at full conversion via the s-
trans amide diastereomers following N-Boc protection (Scheme 12). 
 
Scheme 12. Expected interconversion of the s-cis amide at high temperature to the s-trans amide 
able to undergo radical cyclization. 
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Figure 10. 13C NMR spectrum of the sulfanyl amides 16 shown over the 0 to 75 ppm (top) and 100 
to 180 ppm (bottom) ranges respectively.  
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 With the requisite sulfanyl amides 16 in hand, the final operation that remained in 
the synthesis of the radical cyclization precursor 17 was N-Boc protection of the indole 
moiety.   
 This was achieved through treatment of sulfanyl amides 16 (~3 g scale) with di-tert-
butyl dicarbonate followed by 4-dimethylaminopyridine at room temperature for 2 h 
(Scheme 13). TLC analysis once again showed the clean conversion of the starting 
material to two less polar spots as expected. The desired N-Boc-protected sulfanyl amides 
17 were isolated in quantitative yield following subsequent concentration in vacuo and 
flash chromatography processes.  
 
Scheme 13. Reagents and conditions: (Boc)2O (1.3 equiv), DMAP (0.05 equiv), THF, rt, 2 h, 
100%. 
  1H and 13C NMR spectroscopy provided evidence for the successful installation of 
the N-Boc group (Figure 11). The 1H NMR spectrum of 17 showed the four requisite 
diastereomer/rotamer N-Boc singlets at 1.69, 1.70, 1.79 and 1.81 ppm which indicated that 
the N-Boc group adopted a single conformation, most likely as the cis amide with the 
carbamate carbonyl group pointing towards H-3 on steric grounds (see calculations later in 
section 2.3). The relevant N-Boc ester signals were also seen in the 13C NMR spectrum 
around 29, 85 and 150 ppm for the primary, quaternary and carbamate carbons 
respectively. Deshielding of the H-3 singlet resonances from the prior 6.4 and 7.4 ppm 
regions (Figure 9) to the 7.2 and 8.0 ppm regions was also observed, with the 
corresponding 13C resonances also shown to be slightly deshielded. Furthermore, all the 
other resonances in both the 1H and 13C NMR spectra remained mostly unchanged and for 
simplicity have not been labelled in Figure 11. Finally, HRMS data gave a molecular ion [M 
– SPh]+ at 453.2396 in which C26H33N2O5+ requires 453.2389, thus offering conclusive 
evidence for the formation of the desired precursor 17. 
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Figure 11. 1H (top) and 13C (bottom) NMR spectra of the N-Boc protected sulfanyl amides 17. 
 
46 
 
2.2.3 D-Ring Construction via Radical Cyclization 
 The successful synthesis of the radical cyclization precursor 17 meant that the key 
radical cyclization step could finally be attempted. Overall, this step was repeated several 
times in order to determine the optimal reaction conditions, in which it was found that the 
slow addition of the radical initiator under dilute conditions (0.01 M) and lowering the 
equivalents of tributyltin hydride from 1.5 to 1.3 equivalents minimized the formation of the 
radical reduction product as well as increased the yield and diastereoselectivity.    
 Making use of these optimized conditions (Scheme 14), the N-Boc protected 
sulfanyl amides (17, ~3 g scale) were treated with tributyltin hydride in deoxygenated 
toluene at room temperature and then immediately heated to reflux. The radical initiator 
1,1'-azobis(cyclohexanecarbonitrile) was then slowly added over a 1 h period and the 
solution refluxed (110 °C) for a further 2 h. Meticulous TLC analysis showed the 
disappearance of the starting material after this time and the formation of one major and 
one minor closely running, slightly more polar spot, as well as several smaller, slightly 
more polar spots. The reaction mixture was then left to cool to room temperature and 
concentrated in vacuo. Careful chromatography of the resulting residue did not, however, 
allow for the complete separation of the major and minor isomers. In view of this, the yields 
were corrected via 1H NMR estimation and were found to be 85% (corrected, major-18) 
and 8% (corrected, minor-18) respectively in a diastereomeric ratio of 10:1.         
 
Scheme 14. Reagents and Conditions: Bu3SnH (1.3 equiv), ACCN (0.1 equiv), PhMe, reflux, 3 h, 
85% (major, corrected), 8% (minor, corrected), dr = 10:1. 
 At this point, the stereochemistries at the D/E-ring junction for the two 
diastereomers isolated were unknown, as indicated in Scheme 14. We therefore sought 
confirmation of these assignments through 1H NMR spectroscopy and X-Ray analysis.  
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 The 1H NMR spectrum of the major-18 product (with a small amount of the minor-18 
product still present, ~11%) was now much more resolved and promisingly displayed all of 
the requisite peaks of the desired lactam as highlighted in Figure 12. The previously vinylic 
H-17 proton was now seen as two overlapping doublet of doublet aliphatic resonances at 
1.88 and 1.96 ppm integrating for 2H as expected. Similarly, the previously vinylic H-14 
proton was observed as a multiplet in the 3.16 to 3.25 ppm range, thus overall confirming 
the loss of the double bond. The H-3 resonance was shielded relative to the cyclization 
precursor and appeared at 5.47 ppm as a broad doublet with a 3.6 Hz coupling to the 
adjacent H-14 proton, upfield now compared to the precursor 17 on account of having lost 
the phenylthio group. 
 In view of our previous model (Figure 3, Chapter 1), we expected that the H-3 
proton should be in an axial position due to the indole moiety adopting an equatorial 
orientation on steric grounds. We postulated that the desired cis arrangement of the H-
3/H-14 protons should therefore display an Hax/Heq coupling between H-3 and H-14. If the 
D-ring adopted a chair-like conformation we would expect to see an Hax/Heq coupling of 
approximately 4 Hz. In this system, however, we expected a level of distortion from the 
chair conformer, so a slightly lower 3.6 Hz coupling for an Hax/Heq relationship seemed 
reasonable (Figure 12). That still left the question of the H-3/H-14 to H-20 relationship, and 
so further analysis was carried out later on through single crystal X-ray structure 
determination of the pentacycle following E-ring formation, which will be presented in due 
course. 
 In addition, the 1H NMR spectrum of the major lactam 18 displayed several other 
interesting aspects. The protons situated on the primary carbon of the ethoxy group were 
seen to be slightly more shielded relative to the H-18 protons and appeared as a triplet at 
0.99 pm while the H-18 triplet appeared at 1.02 ppm. The diastereotopic H-15 protons 
were observed at 1.10 and 2.50 ppm showing a significant 1.4 ppm separation, with one of 
the diastereotopic protons more shielded relative to the H-19 protons. Finally, the H-5 
resonances once again showed a remarkable ~2 ppm separation between its 
diastereotopic protons at around 2.9 and 4.9 ppm respectively. 
 Furthermore, at this point we should note that the H-3 signal in the 1H NMR 
spectrum of the minor-18 product was buried and not clearly discernible, meaning that the 
H-3/H-14 coupling and insight therefore into the D/E-ring junction stereochemistry could 
not be obtained from it. As a result of this, we pushed forward with the major-18 product in 
the remaining steps and discarded trace amounts of the minor products along the way. 
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 The identity of the minor-18 lactam was confirmed later on through computational 
analysis in section 2.3. 
 
Figure 12. 1H NMR (top) and HSQC (bottom) spectra of the major lactam 18. 
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 The 13C NMR spectrum of the major lactam 18 displayed a total of 24 peaks 
corresponding to the requisite 24 distinct magnetically equivalent carbon environments as 
shown in Figure 13. C-14 and C-17 were now seen as the tertiary and secondary carbon 
signals at 34.1 and 36.7 ppm respectively with C-17 now shown to be deshielded relative 
to C-14 as expected. In addition, the C-3 signal was seen to be shielded (relative to the 
precursor) at 54.2 ppm, therefore providing indisputable evidence in favour of D-ring 
formation. Interestingly, the C-16 ester carbonyl was observed to be deshielded at 175.0 
ppm relative to the C-21 lactam carbonyl at 172.1 ppm likely due to the loss of its α,-
unsaturated ester character. 
 
Figure 13. 13C NMR spectrum of the major lactam 18. 
 Finally, further evidence for the formation of the desired lactam 18 was obtained via 
HRMS which revealed a molecular ion [M + H]+ at 455.2554 corresponding to the required 
455.2548 calculated for C26H35N2O5+.   
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2.2.4 End-Game Strategy I 
 With reproducible access to the desired major lactam 18 (~2 g), we then sought to 
tackle what remained of our route, namely, N-Boc deprotection, E-ring formation and 
chemoselective lactam reduction. 
 Initially we attempted to remove the N-Boc group of lactam 18 via the standard 
deprotection conditions through treatment with trifluoroacetic acid at 0 °C in the presence 
of anisole as the cation scavenger (Scheme 15). Unfortunately, although TLC analysis 
showed the consumption of the starting material, several products were formed. We 
postulated that the free indole was likely too sensitive under acidic conditions and that this, 
in conjunction with the presence of the nearby reactive ester group, could thus have 
resulted in partial formation of the E-ring cyclized product. In view of this, we sought an 
alternative methodology for the removal of the N-Boc group, which was found in the form 
of thermolytic conditions (Scheme 15).17 
 
Scheme 15. Reagents and Conditions: neat, 180 °C, 30 min, 87% (corrected). 
 The method from which the desired product emerged successfully involved heating 
major lactam 18 (neat under argon, ~300 mg scale, still containing ~11% minor-18) at 180 
°C for 30 minutes. Careful chromatography of the resulting residue allowed for the partial 
removal of the minor-30 product, and afforded the desired deprotected major lactam 30 in 
87% corrected yield. Through careful monitoring we found that heating at a higher 
temperature (~190 °C) or for a longer reaction time resulted in the formation of several 
spots on TLC and decomposition of the product, while heating at a lower temperature 
(~170 °C) or for a shorter reaction time (~20 min) did not allow for the reaction to go to 
completion.  
 1H NMR spectroscopic analysis of the major-30 product (with ~6% of the minor-30 
product now present) showed the disappearance of the N-Boc signal along with the 
appearance of a new NH signal, as expected (Figure 14). The H-3 and H-5 signals were 
seen to be slightly shielded while the H-18 resonance was now seen to be shielded 
relative to the primary ethoxy protons.  
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 In addition, the H-3 doublet was now more resolved, and displayed a standard 
Hax/Heq 4.1 Hz coupling with H-14, thus providing further evidence for the formation of the 
desired cis H-3/H-14 D/E-ring junction.  
 
 
Figure 14. 1H NMR (top) and HSQC (bottom) spectra of deprotected lactam 30. 
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 At this stage, with the deprotected lactam 30 in hand, a strategic decision to cyclize 
to the dilactam 19 (Scheme 16) was made, since we believed that we might be able to 
chemoselectively reduce the C-21 lactam in the presence of the C-16 lactam in the 
following step. To this end, lactam 30 was immediately cyclized to pentacycle 19 following 
pyrolysis owing to its instability in air (stable under argon). E-ring formation was achieved 
swiftly under basic conditions in near quantitative yield as shown in Scheme 16. Following 
extraction and purification by flash chromatography the major pentacycle 19 could be 
isolated cleanly as a single diastereomer, and was pleasingly obtained as a pale yellow 
solid (the prior lactam products 18 and 30 were both isolated as gums). 
 
Scheme 16. Reagents and Conditions: NaH (1.1 equiv), THF, 0 °C, 1 h, 99%. 
 Given the fact that the cis H-3/H-14 to H-20 relationship had not yet been 
ascertained, we sought conclusive evidence in the form of an X-ray crystal structure 
determination of the pentacycle 19 following recrystallization. Much to our delight, we 
found that 19 did indeed display the required all cis H-3 to H-14 to H-20 relationship as 
indicated in Figure 15 below. The X-ray structure shows the C/D-ring fusion to be cis, in 
which pseudo-equatorial configurations are adopted for both the large indole moiety as 
well as the D-ring ethyl group, albeit that the D-ring adopts a flattened pseudo-chair due to 
the lactam functionality. 
 
 
 
 
 
 
 
 
Figure 15. X-ray crystal structure of the pentacycle 19 displaying the desired all cis H-3 to H-14 to 
H-20 relationship. 
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 With the requisite H-3, H-14 to H-20 stereochemical relationship of the pentacycle 
19 fully established, we then moved on to attempt the chemoselective reduction process. 
 In this, we postulated that chemoselectivity differentiation might be achieved due to 
the C-21 lactam carbonyl oxygen being more nucleophilic and its carbonyl carbon less 
electrophilic compared to those atoms in the C-16 lactam, which was deemed to be less 
nucleophilic at oxygen but more electrophilic at carbon due to delocalization of its nitrogen 
lone pair into the indole π-system (see numbering in 19, Scheme 17). In view of this, 
standard nucleophilic lactam reducing agents such as lithium aluminium hydride would 
likely result in the undesired reduction of the C-16 lactam in favour of the C-21 lactam. 
Thus, we went in search of other reduction strategies that would favour reduction of the C-
21 lactam. 
 Looking through the literature, we were aware that thionation of a lactam moiety 
could be achieved in the presence of an ester with Lawesson's reagent due to the more 
nucleophilic character of an amide carbonyl oxygen over that of an ester.18-21 Therefore, 
we postulated that in our system, chemoselective thionation of the more nucleophilic C-21 
lactam could take place in the presence of the C-16 indole lactam. Further reduction of the 
thiolactam with Raney Nickel was then envisaged for the conversion of the thiolactam to 
the target in an overall two step thionation/reduction process (Scheme 17). 
 To this end dilactam 19 was subjected to the standard thionation conditions through 
treatment with Lawesson's reagent and refluxing in toluene.18 Unfortunately, TLC analysis 
showed the formation of several product spots without full conversion of the starting 
material even after refluxing for several hours. Further 1H NMR analysis of the products 
did not look promising either and suggested possible epimerization of the C-20 centre as 
well as dithionation of both the lactam entities.  
 
Scheme 17. Unsuccessful thionation/reduction process for the conversion of dilactam 19 to the 
target 1. 
 As a consequence of this unfortunate outcome we were forced to review our 
synthetic route. 
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2.2.5 End-Game Strategy II 
  At this juncture we envisaged an alternative strategy inspired by finding the work 
undertaken by Schultz et al. in 1997, wherein they were able to generate the E-ring 
through an oxidation/ring-closing process in high yield in their synthesis of (-)-vincamone 
(Scheme 18).22  
 
Scheme 18. Final oxidation/E-ring formation step in the Schultz et al. synthesis of (-)-vincamone.22 
 With this disconnection in mind we opted to revert back to the deprotected lactam 
30 (Scheme 19). From this point, we then envisaged global reduction of both the amide 
and ester moieties followed by oxidation/closing through the method of Schultz et al. as 
shown in Scheme 19.      
 
Scheme 19. Modified synthetic strategy for the conversion of the deprotected lactam 30 to the 
target 1. 
 Naturally, we first attempted the global reduction of lactam 30 through treatment 
with lithium aluminium hydride at 0 °C (Scheme 20). TLC analysis showed partial 
conversion of the starting material likely to the reduced ester product only. Upon heating to 
reflux we observed the formation of the desired product along with the formation of several 
other products which was thus attributed to product instability at a higher temperature over 
longer reaction times. Several other attempts at this transformation involved varying the 
number of equivalents of the reagent used, lowering the temperature in an effort to control 
the step-wise reduction process, and varying the reaction times were all met with little 
success and in very low yield following isolation of the alcohol 31 (~15-30%). 
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Scheme 20. Early attempts at the global reduction process. 
 In addition to the use of lithium aluminium hydride, various other standard reducing 
agents were tested including lithium borohydride, sodium borohydride/boron trifluoride 
diethyl etherate as well as borane dimethyl sulfide,23 none of which led to the formation of 
the desired product and only achieved partial conversion of the starting material. In view of 
this series of disappointing results, we went in search for other lactam reducing agents that 
had been used in similar contexts in the literature. 
 In their 2016 synthesis of (-)-3-epitacamonine, Argade et al. used aluminium 
hydride (more colloquially known as alane) for the reduction of the lactam moiety bearing 
an adjacent C-20 ethyl group, with simultaneous removal of the pivaloyl protecting group, 
as shown in Scheme 21.24  
 
Scheme 21. Lactam reduction/pivaloyl deprotection step in the Argade et al. synthesis of  
(-)-3-epitacamonine.24 
 This method appealed to us since it indicated that both the lactam and ester 
functionalities could be reduced in reasonable yield and at a lower temperature without the 
need for reflux, since we already had cause for concern regarding the instability of our 
precursor at higher temperatures over longer reaction times. In addition, it confirmed that 
the lactam could be reduced in the presence of the adjacent C-20 ethyl group without loss 
of the C-20 stereogenicity. Another potential cause for concern in our case was the lack of 
the indole N-Ts protecting group used by the Argade group. Nevertheless, we proceeded 
to subject our lactam 30 to these conditions in the hope that we were later able to adjust 
the conditions to better suit our slightly more sensitive substrate. 
  
56 
 
 Much to our relief, our initial efforts provided promising results. Though at this stage 
the reaction profile did not seem to be particularly clean by TLC analysis at room 
temperature, it showed complete conversion of the starting material, along with the 
formation of a dominant more polar spot which, up until this point, we had not observed 
through the use of any other reducing agent. After further optimization of the conditions 
(shown in Scheme 22) we were able to isolate the desired alcohol in 63% crude yield. 
 
Scheme 22. Reagents and Conditions: AlH3 (4 equiv), THF, –40 to 0 °C, 6 h, 63%. 
 In this (Scheme 22), reduction of the ester functionality was observed through low 
temperature treatment of the lactam 30 with aluminium hydride at –40 °C over 30 min. The 
reaction mixture was then stirred at this temperature for a further 30 min before being 
allowed to warm to 0 °C. 5 h of meticulous TLC analysis at this temperature confirmed the 
formation of the desired alcohol product 31. The reaction mixture was then quenched 
through the careful addition of an aqueous saturated sodium sulfate solution, filtered 
through Celite and the filtrate concentrated in vacuo.  
 Crude 1H NMR analysis of the alcohol 31 showed the loss of the ethoxycarbonyl 
proton resonances along with the appearance of new H-21 signals. IR spectroscopy also 
confirmed the loss of both the lactam and ester peaks at 1654 and 1726 cm-1 respectively. 
At this point, given the high polarity of the alcohol and our lack of material, we decided to 
push on to the final oxidation/closing step forgoing further purification in an effort to avoid 
potential losses through column chromatography. 
 Therefore, in the final step (Scheme 23) following the procedure of Schultz et al.,22 
crude alcohol 31 was treated with tetrapropylammonium perruthenate and N-
methylmorpholine N-oxide at room temperature. The reaction mixture was then stirred for 
a further 3 h, during which time TLC analysis confirmed conversion of the alcohol to a 
dominant less polar spot.  
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 Subsequent filtration, extraction and flash chromatography processes allowed for 
the clean isolation of the target 1 as a single diastereomer, which was obtained as long, 
clear, colourless needles in 45% yield over 2 steps from 30 and in 96% ee as ascertained 
by chiral HPLC on an OD column. 
 
Scheme 23. Reagents and Conditions: TPAP (0.2 equiv), NMO (2 equiv), CH2Cl2 (treated with 4 Ǻ 
molecular sieves), rt, 3 h, 45% (over 2 steps). 
 Following recrystallization from ethyl acetate/hexane, the melting point was 
obtained as 179 – 181 °C, in full agreement with the literature value reported by Van Beek 
et al. in their original work (180 – 181 °C).4 1H and 13C NMR data of the product obtained 
(shown in Figures 16 and 17) were once again in full agreement with those of the literature 
for (+)-tacamonine published by Van Beek et al.4 and Lounasmaa et al.25 respectively. A 
full comparison is shown in Table 1 for brevity. Furthermore, IR spectroscopy confirmed 
the re-appearance of the C-16 lactam signal at 1701 cm-1. HMRS data gave a molecular 
ion [M + H]+ at 295.1820 in agreement with 295.1812 calculated for C19H23N2O+. Finally, 
the optical rotation of the target 1 was found to be +117.2, in close agreement with the 
literature value of +122 reported by Danieli et al.26 
 X-ray crystal structure determination of the target 1 (Figure 18), belonging to a 
monoclinic crystal system and crystallizing in the P 21 space group, provided conclusive 
evidence for its formation. Similar to the crystal structure of the pentacycle 19 (Figure 15), 
it revealed the requisite cis H-3/H-14 to H-20 relationship, with the large indole moiety 
once again adopting a pseudoequatorial orientation, while the D-ring was now seen in the 
chair conformation owing to the loss of the sp2 lactam system placing the C-20 ethyl group 
'down' in the more stable equatorial position. Once again, the C/D-ring junction was also 
cis, to  accommodate the D/E cis ring-junction stereochemistry.   
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Figure 16. 1H NMR (top) and HSQC (bottom) spectra of (+)-tacamonine (1). 
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Table 1. 1H and 13C NMR literature data comparison for (+)-tacamonine. 
1H 
NMR 
Van Beek et al.4 
δ (ppm) 
Data obtained 
δ (ppm) 
H-3 4.33 (m, 1H) 4.42 – 4.38 (m, 1H) 
H-5a 3.30 (m, 1H) 3.42 – 3.33 (m, 2H) H-5b 3.38 (m, 1H) 
H-6a 2.48 (br ddd, J = 17.0, 7.1, 3.1 Hz, 1H) 2.57 – 2.49 (m, 1H) 
H-6b 2.89 (m, 1H) 2.97 – 2.87 (m, 1H) 
H-9 7.43 (m, 1H) 7.46 – 7.43 (m, 1H) 
H-10 7.32 (ddd, J = 7.3, 7.3, 1.8 Hz, 1H) 7.35 – 7.27 (m, 2H) H-11 7.28 (ddd, J = 7.3, 7.3, 1.8 Hz, 1H) 
H-12 8.38 (br dd, J = 7.3, 1.8 Hz, 1H) 8.38 (br dd, J = 7.3, 1.6 Hz, 1H) 
H-14 2.45 (m, 1H) 2.54 – 2.47 (m, 1H) 
H-15a 0.56 (ddd, J = 12.6, 12.6, 12.6 Hz, 1H) 0.58 (ddd, J = 12.9, 12.8, 12.7 Hz, 1H) 
H-15b 1.66 (br d, J = 12.6 Hz, 1H) 1.71 – 1.66 (m, 1H) 
H-17a 2.66 (dd, J = 17.0, 2.3 Hz, 1H) 2.68 (dd, J = 17.0, 2.2 Hz, 1H) 
H-17b 2.99 (dd, J = 17.0, 4.9 Hz, 1H) 3.01 (dd, J = 17.0, 4.9 Hz, 1H) 
H-18 0.85 (t, J = 7.4 Hz, 3H) 0.86 (t, J = 7.4 Hz, 1H) 
H-19 1.10 (m, 2H) 1.16 – 1.08 (m, 2H) 
H-20 1.52 (m, 1H) 1.63 – 1.54 (m, 1H) 
H-21a 2.03 (dd, J = 11.0, 10.9 Hz, 1H) 2.07 (t, J = 11.0 Hz, 1H) 
H-21b 2.64 (ddd, J = 10.9, 3.7, 1.7 Hz, 1H) 2.71 – 2.66 (m, 1H) 
13C 
NMR 
Lounasmaa et al.25 
δ (ppm) 
Data obtained 
δ (ppm) 
C-2 131.5 131.4 
C-3 53.2 53.5 
C-5 50.2 50.4 
C-6 16.3 16.5 
C-7 112.7 112.9 
C-8 129.8 130.0 
C-9 118.0 118.3 
C-10 123.7 124.1 
C-11 124.3 124.7 
C-12 116.2 116.5 
C-13 134.3 134.7 
C-14 34.3 34.5 
C-15 31.9 32.0 
C-16 167.3 167.4 
C-17 39.6 39.8 
C-18 11.3 11.4 
C-19 26.8 27.0 
C-20 37.6 37.6 
C-21 50.5 50.7 
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Figure 17. 13C NMR spectrum of (+)-tacamonine (1). 
 
Figure 18. X-ray crystal structure of the target (+)-tacamonine (1) displaying the desired all cis H-3 
to H-14 to H-20 relationship. 
 In summary, we were able to synthesize the target (+)-tacamonine in 8 steps over 
10 distinct operations in 25% overall yield and in 96% ee. Our synthesis is thus, to the best 
of our knowledge, the shortest and mostly highly efficient route developed to date. 
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2.3 Computational Modelling of the Radical Cyclization 
 With our stereoselective route to (+)-tacamonine firmly in place, we then set out to 
investigate the diastereoselectivity of the radical cyclization which was obtained as a 10:1 
diastereomeric ratio with the major-18 product confirmed to be the all cis H-3 to H-14 to H-
20 diastereomer as shown in Scheme 24. At this stage, however, we had not yet 
confirmed the minor-18 products D/E cis/trans ring-junction as well as the relative H-3/H-
14 to H-20 stereochemistry.  
 
Scheme 24. A review of the radical cyclization diastereoselectivity. 
 In order to address this issue, we first noted that the radical cyclization step could 
lead to the formation of four possible products as shown in Figure 19. For convenience 
these were labelled the up/up, down/down, down/up and up/down products 
respectively.   
 
Figure 19. A depiction of the four possible radical cyclization products. 
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 Since we had already established that the major-18 product was indeed the up/up 
product, we assumed that it had the lowest energy transition state relative to the other 
products. Therefore, we postulated that the second lowest energy transition state would 
thus lead to the formation of the minor-18 product. With this in mind, we set out to 
calculate the relative transition state energies leading to the four possible products shown 
in Figure 19, in order to confirm the identity of the minor-18 product. 
 To this end, we opted to model the transformation from the radical reactant to each 
of the radical products as shown in Scheme 25 through computational methods (see 
Chapter 3 section 3.3 for further details).        
 
Scheme 25. An illustration of the radical reactant and radical products used in the computational 
modelling of the radical cyclization step. 
 In this, we began by calculating the minimum energy conformation of the radical 
reactant, as well as the energies of the radical products. The four radical transition states 
were then found in a separate calculation. This was done by first starting with each radical 
product structure and scanning the bond being formed from its product bond length in 20 
steps of +0.1 Ǻ. The maximum energy point along the resultant path was then used as a 
starting point for the transition state optimization, which was based on the same 
mechanics as the regular procedure, and adjusted to search for a first order saddle point. 
Once the transition states had been found and optimized, the activation energies from the 
radical reactant leading to each of the four possible transition states were computed. 
 Through our experimental observations and X-Ray analysis, we already knew that 
the up/up transition state was likely the lowest in activation energy, unless thermodynamic 
control were to be operating which was considered to be unlikely (see rationale later in 
Scheme 26). Therefore, we opted to assign the up/up transition state an activation energy 
value of 0 kJ.mol-1, from which the relative activation energies of the three other transition 
states were calculated. A summary of the relative activation energies obtained for each of 
the four possible radical transition states labelled TS-1, TS-2, TS-3 and TS-4 (in order to 
those shown in Figure 19) are in turn shown in Figure 20.          
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 The results of our calculations (Figure 20) reinforced our experimental observations. 
Indeed, TS-1, leading to the major cis up/up diastereomer, was found to have the lowest 
relative activation energy as expected. Moreover, the transition state with the second 
lowest relative activation energy was higher by +11.3 kJ.mol-1 and traced to TS-3, 
corresponding to the minor-18 product (Scheme 24) as the trans down/up diastereomer 
as shown in Figure 19. The relative activation energies of the cis down/down (via TS-2) 
and trans up/down (via TS-4) diastereomers were also found to be +16.6 kJ.mol-1 and 
+35.0 kJ.mol-1 respectively.   
 
 
Figure 20. A depiction of the four possible radical cyclization transition states with their associated 
relative transition state energies. Calculations done using PW6B95–D3/def2–QZVP//TPSS–
D3/def2–TZVP. Toluene solvent included using SMD. RRHO correction to free energy obtained 
from vibrational frequency analysis at TPSS–D3/def2–TZVP. 
  
  
Major up/up (TS-1) 
G‡rel = 0.0 kJ.mol-1 
down/down (TS-2) 
G‡rel = +16.6 kJ.mol-1 
up/down (TS-4) 
G‡rel = +35.0 kJ.mol-1 
Minor down/up (TS-3) 
G‡rel = +11.3 kJ.mol-1 
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 At this stage, however, we should note that the radical cyclization is a two-step 
process overall, the first of which is the formation of the cyclized radical, followed by 
hydrogen addition to form the product as shown in Scheme 26. 
 
 
Scheme 26. Delineation of the two step radical process from the radical reactant to the products. 
 In the second step of this process (Scheme 26), we should note the formation of the 
strong C-H bond (452 kJ.mol-1) at the expense of the much weaker H-Sn bond (267 
kJ.mol-1).27 This large difference in bond strengths meant that the second step (k2) would 
likely happen much more rapidly compared to equilibration in the first (k-1), implying that  
the rate of the reaction is dependent on the rate of the initial cyclization, and thus, that 
there is no appreciable equilibration in the first cyclization step (k2 > k-1). 
 In view of this, we looked to model the rate-determining cyclization in the form of a 
reaction energy diagram. With the computed the minimum energy of the radical reactant, 
the activation energies of each of the transition states, and the energies of the four 
possible radical products in hand, we were able to construct the reaction energy profile 
shown in Figure 21.  
 The reaction energy diagram obtained highlighted several interesting aspects 
(Figure 21). Firstly, it indicated that both the up/up TS-1 as well as the up/up radical 
product were lowest in relative energy, in full agreement with our experimental 
observations. Secondly, it indicated that the radical to radical cyclization is endergonic 
(G>0, non-spontaneous), meaning that the cyclized radical products are higher in energy 
than the radical reactant.  
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Figure 21. Reaction energy profile of the radical to radical cyclization step (Scheme 25). 
Calculations done using PW6B95–D3/def2–QZVP//TPSS–D3/def2–TZVP. Toluene solvent 
included using SMD. RRHO correction to free energy obtained from vibrational frequency analysis 
at TPSS–D3/def2–TZVP. 
 This can be rationalized by the loss of entropy (due to loss of degrees of freedom) 
as well as an  increase in enthalpy (due to increased non-bonding interactions as well as 
π- to σ-bond formation) going from the radical reactant to the radical product, resulting in 
an overall G>0 according to G = H – TS. This also implied a degree of reversibility, 
which would in turn depend on the rate of the second hydrogen reduction. Since we had 
already postulated that the rate of the second step (k2) would be much faster (higher), we 
assumed that the degree of reversibility would thus be negligible. These insights indicate 
that the reaction overall likely proceeds under kinetic control, which in turn meant that the 
relative activation energies calculated for each of the transition states (Figure 20) would 
determine the diastereomeric ratio as reflected in the products. 
 Furthermore, the exact nature of the interplay of non-bonded interactions and 
conformational aspects determining the relative order of activation energies leading to 
TS1-4 is complex and somewhat beyond the scope of this dissertation. The nature of the 
enoate ester stacking relative to the indole ring, the configurational preference of the C-20 
ethyl group, as well as the nature of the D-ring as it folds as either chair- or boat-like, no 
doubt all play their roles 
Reactant 
TS-1 
TS-2 
TS-3 
TS-4 
Major u/u 
Minor d/u 
d/d 
u/d 
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2.4 Conclusions 
 As detailed in the previous sections, we have developed a novel strategy for the 
asymmetric synthesis of (+)-tacamonine proceeding over 8 steps from commercially 
available materials in 10 distinct operations, making it the shortest known route developed 
to date (summarized in Scheme 27). 
 
Scheme 27. A summary of our route to the target (+)-tacamonine. 
 Our highly-efficient strategy allowed for the synthesis of the target in 25% overall 
yield and in 96% enantiomeric access. Furthermore, computational investigation of the 
kinetically controlled diastereoselective radical cyclization procedure suggested the 
formation of a major product coinciding with our experimental observations. This novel 
route along with our computational calculations will be published in due course.      
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Experimental 
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3.1 General Procedures 
 All reagents were purchased from Sigma-Aldrich or Merck at the highest 
commercial quality and used without further purification. All dry solvents used were freshly 
distilled. Dichloromethane was distilled under nitrogen from phosphorus pentoxide. 
Tetrahydrofuran was distilled under nitrogen from sodium wire with benzophenone. 
Toluene was distilled under nitrogen from calcium hydride. All reactions were carried out 
under an argon atmosphere with dry solvents under anhydrous conditions unless 
otherwise stated. Low temperature reactions were carried out in an acetone bath cooled 
by liquid nitrogen to –78 °C unless otherwise stated. Reactions were magnetically stirred 
and monitored by thin-layer chromatography (TLC) carried out on aluminium-backed 
Merck silica-gel 60 F254 plates using UV light, iodine vapour and/or spraying with a 2.5% 
solution of anisaldehyde in a 10% sulfuric acid/ethanol mixture followed by heating as 
visualizing agents. Column chromatography was performed using Merck silica-gel (pore 
size 60 Ǻ, 230 mesh). The enantiomeric excess (ee) and diastereomeric ratio (dr) values 
were calculated from peak area percentages obtained via high performance liquid 
chromatography (HPLC) using an Agilent Technologies 1220 Infinity LC instrument 
equipped with a UV detector. Specific rotations (      ) of optically active compounds were 
obtained using a Perkin Elmer 343 polarimeter at 20 °C and λ = 589 nm. The 
concentrations (c) of the samples used are given in g/100ml. Electron-ionization high 
resolution mass spectrometry (HRMS) was performed using a Direct Probe JEOL GCmate 
II instrument. Melting points were obtained using a Reichert Jung Thermovar hot-stage 
microscope and are uncorrected. Infrared (IR) absorptions were measured using a Bruker 
Tensor27 platinum ATR instrument. Nuclear magnetic resonance (NMR) spectra were 
recorded on either Bruker Ultrashield 400 Plus or Bruker 300 instruments and were carried 
out in chloroform-d unless otherwise stated. Chemical shifts (δ) were recorded in ppm 
relative to residual chloroform resonances at 7.26 and 77.16 in 1H NMR and 13C NMR 
respectively unless otherwise stated. All the structures are numbered relative to the natural 
(+)-tacamonine numbering convention.1  
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N-Formyltryptamine 242 
 
 Excess ethyl formate (80 mL) was added to a flask containing tryptamine (10.0 g, 
62.4 mmol, 1.0 equiv) and the stirred suspension immediately heated to 60 °C for 1 h then 
left to stir overnight at 70 °C. After 17 h the solution was allowed to cool to room 
temperature and the remaining ethyl formate was removed in vacuo to yield crude 24 (12.7 
g) as a brown oil2 that was used immediately in the next step. 
 
3,4-Dihydro--carboline 83 
 
 Excess phosphoryl chloride (55 mL, 590. mmol, 8.7 equiv) was slowly added to a 
flask containing the crude 24 (12.7 g, 67.5 mmol, 1.0 equiv) at 0 °C over 15 min and then 
left to stir at room temperature. After 1.5 h the excess phosphoryl chloride was removed by 
distillation and H2O (1000 mL) was slowly added to the crude residue at 0 °C with stirring, 
after which the aqueous mixture was filtered to remove a black solid precipitate that 
formed during the addition. The filtrate was then basified with concentrated aqueous 
ammonia from which 3,4-dihydro--carboline 8 separated as a pale yellow micro-
crystalline solid3 (10.2 g, 96% yield over 2 steps). The resulting crude product was 
deemed pure enough by 1H NMR spectroscopy to be used in the following coupling step 
without further purification. 
 Mp = 173 – 176 °C (Literature3 = 175 – 176 °C); 1H NMR (300 MHz, CDCl3) δ 8.71 
(br s, 1H, N-H), 8.38 (br s, 1H, H-3), 7.59 (d, J = 8.0 Hz, 1H, H-12), 7.39 (d, J = 8.2 Hz, 1H, 
H-9), 7.28 (t, J = 7.1 Hz, 1H, H-10), 7.15 (t, J = 7.1 Hz, 1H, H-11), 3.89 (m, 2H, H-5), 2.90 
(t, J = 8.3 Hz, 2H, H-6). 
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Butyryl oxazolidinone 214 
 
 (S)-4-Benzyl-2-oxazolidinone (863 mg, 4.87 mmol, 1.0 equiv) was dissolved in THF 
(20 mL) and cooled to –78 °C before n-BuLi (1.6 M solution in hexanes, 3.35 mL, 5.36 
mmol, 1.1 equiv) was added dropwise over 5 min. After stirring for a further 30 min at –78 
°C, freshly distilled butyryl chloride (0.71 mL, 6.82 mmol, 1.4 equiv) was added dropwise 
and the mixture left to warm to room temperature slowly over 4 h. At this point saturated 
aqueous NH4Cl (20 mL) was added and the reaction contents transferred to a separatory 
funnel, diluting with water (30 mL) and CH2Cl2 (50 mL). The layers were separated and the 
aqueous layer extracted a further two times with CH2Cl2 (50 mL). The combined organic 
layers were dried with MgSO4, filtered and concentrated in vacuo. The resulting product 
was purified by flash chromatography (silica gel, EtOAc/hexanes, 0% to 15%) to give 21 
(1.177 g, 98%) as a colourless syrup. The data given below is in agreement with the 
literature data.4  
         = +53.8 (Literature
4 = +52.4, c = 1, CHCl3); ee found as 98% by HPLC (Daicel 
Chiralcel OD column, 0.46 cm × 25 cm, 10% i-PrOH/hexane, 1 mL/min,  major = 11.2 min, 
 minor = 14.1 min); IR (neat) νmax 1774 (carbamate, C=O), 1696 (C-21, C=O) cm-1; 1H NMR 
(400 MHz, CDCl3) δ 7.34 – 7.31 (m, 2H, Ph-H), 7.29 – 7.26 (m, 1H, Ph-H), 7.21 (d, J = 6.9 
Hz, 2H, Ph-H), 4.70 – 4.66 (m, 1H, (PhCH2)CH), 4.21 – 4.15 (m, 2H, (PhCH2)CH(CH2O-)), 
3.30 (dd, J = 13.4, 3.2 Hz, 1H, (PhCHaHb)CH), 2.98 – 2.93 (m, 1H, H-20b), 2.91 – 2.85 (m, 
1H, H-20a), 2.77 (dd, J = 13.4, 9.6 Hz, 1H, (PhCHaHb)CH), 1.77 – 1.70 (m, 2H, H-19), 1.01 
(t, J = 7.4 Hz, 3H, H-18); 13C NMR (101 MHz, CDCl3) δ 173.4 (C-21), 153.6 (-O(C=O)N-), 
135.5 (C-arom), 129.6 (2C-arom), 129.1 (2C-arom), 127.5 (C-arom), 66.3 
((PhCH2)CH(CH2O-)), 55.3 ((PhCH2)CH(CH2O-)), 38.1 ((PhCH2)CH(CH2O-)), 37.5 (C-20), 
17.9 (C-19), 13.8 (C-18); HRMS (ESI) calcd for C14H17NO3Na+ [M + Na]+ requires 
270.1105, found 270.1105.    
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Allylated oxazolidinone 225 
 
 NaHMDS (1.0 M solution in THF, 5.24 mL, 5.24 mmol, 1.1 equiv) was added to a 
solution of 21 (1.177 g, 4.76 mmol, 1.0 equiv) in THF (20 mL) at –78 °C dropwise over 15 
min with stirring. After stirring for a further 30 min, allyl bromide (1.03 mL, 11.9 mmol, 2.5 
equiv) was added to the reaction mixture at –78 °C over 5 min, and the reaction mixture 
allowed to warm to –20 °C slowly over 5 h. The reaction mixture was quenched with 
saturated aqueous NH4Cl (20 mL) and transferred to a separatory funnel, diluting with 
water (30 mL) and CH2Cl2 (50 mL). The layers were separated and the aqueous layer 
extracted a further two times with CH2Cl2 (50 mL). The combined organic layers were dried 
with MgSO4, filtered and concentrated in vacuo. The resulting product was purified by flash 
chromatography (silica gel, EtOAc/hexanes, 0% to 10%) to give 22 (1.177 g, 86%) as a 
clear, colourless oil. The data that follows is in agreement with the literature data.5   
        = +57.9 (c = 1, CHCl3); dr found as 98:2 by HPLC (Zorbax Eclipse Plus C18 
column, 0.46 cm × 15 cm, 50% H2O/acetonitrile, 1 mL/min,  major = 19.1 min,  minor = 26.8 
min); IR (neat) νmax 1785 (carbamate, C=O), 1697 (C-21, C=O) cm-1; 1H NMR (400 MHz, 
CDCl3) δ 7.34 – 7.32 (m, 2H, Ph-H), 7.28 – 7.26 (m, 1H, Ph-H), 7.22 (d, J = 7.0 Hz, 2H, 
Ph-H), 5.83 (ddt, J = 17.1, 10.0, 7.0 Hz, 1H, H-14), 5.09 (dd, J = 17.1, 1.7 Hz, 1H, H-17b), 
5.04 (dd, J = 10.0, 1.7 Hz, 1H, H-17a), 4.72 – 4.68 (m, 1H, (PhCH2)CH), 4.16 (dd, J = 9.1, 
7.4 Hz, 1H, (PhCH2)CH(CHaHbO-)), 4.14 (dd, J = 9.1, 3.0 Hz, 1H, (PhCH2)CH(CHaHbO-)), 
3.86 (tt, J = 7.9, 5.7 Hz, 1H, H-20), 3.30 (dd, J = 13.4, 3.3 Hz, 1H, (PhCHaHb)CH), 2.68 
(dd, J = 13.4, 10.0 Hz, 1H, (PhCHaHb)CH), 2.51 – 2.46 (m, 1H, H-15b), 2.35 – 2.31 (m, 1H, 
H-15a), 1.79 – 1.72 (m, 1H, H-19b), 1.60 – 1.55 (m, 1H, H-19a), 0.93 (t, J = 7.4 Hz, 3H, H-
18); 13C NMR (101 MHz, CDCl3) δ 176.1 (C-21), 153.3 (-O(C=O)N-), 135.6 (C-arom), 
135.5 (C-14), 129.6 (2C-arom), 129.1 (2C-arom), 127.5 (C-arom), 117.2 (C-17), 66.1 
((PhCH2)CH(CH2O-)), 55.7 ((PhCH2)CH(CH2O-)), 43.9 (C-20), 38.3 ((PhCH2)CH(CH2O-)), 
36.4 (C-15), 24.7 (C-19), 11.7 (C-18); HRMS (ESI) calcd for C17H21NO3Na+ [M + Na]+ 
requires 310.1418, found 310.1419. 
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Free acid 236 
 
 LiOH monohydrate (329 mg, 7.83 mmol, 2.0 equiv) followed by H2O2 (30% solution, 
8.82 M, 2.23 mL, 19.6 mmol, 5.0 equiv) was added to a solution of 22 (1.126 g, 3.92 mmol, 
1.0 equiv) in THF/H2O 5:1 (10 mL) at 0 °C with stirring. After 2 h saturated aqueous 
Na2SO3 was added (10 mL), the excess THF was removed under reduced pressure and 
the contents transferred to a separatory funnel. The aqueous layer was diluted with water 
(10 mL) and washed with CH2Cl2 (3 x 20 mL) to remove free chiral auxiliary (96% 
recovery) and then acidified to pH ~ 1. The acidic solution was extracted with CH2Cl2 (3 x 
20 mL), the organic extracts combined, dried over MgSO4 and concentrated in vacuo to 
give crude 23 in quantitative yield as a clear, colourless oil. 
        = +3.3 (c = 1, CHCl3); IR (neat) νmax 1702 (C-21, C=O) cm
-1; 1H NMR (400 
MHz, CDCl3) δ 5.77 (ddt, J = 17.0, 10.1, 6.9 Hz, 1H, H-14), 5.09 (dd, J = 17.0, 1.7 Hz, 1H, 
H-17b), 5.04 (dd, J = 10.1, 1.7 Hz, 1H, H-17a), 2.42 – 2.37 (m, 2H, H-15), 2.29 – 2.23 (m, 
1H, H-20), 1.69 – 1.64 (m, 1H, H-19b), 1.61 – 1.56 (m, 1H, H-19a), 0.95 (t, J = 7.4 Hz, 3H, 
H-18); 13C NMR (101 MHz, CDCl3) δ 182.1 (C-21), 135.4 (C-14), 117.1 (C-17), 46.8 (C-
20), 35.8 (C-15), 24.7 (C-19), 11.7 (C-18); HRMS (ESI) calcd for C7H11O2– [M – H]– 
requires 127.0757, found 127.0761. 
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Acid ester 15 
 
 Excess ethyl acrylate (4.35 mL, 39.9 mmol, 5.0 equiv) followed by the Hoveyda-
Grubbs 2nd generation catalyst (50.0 mg, 0.080 mmol, 0.01 equiv) was added to a solution 
of crude free acid 23 (1.023 g, 7.98 mmol, 1.0 equiv) in dry, degassed (by 15 min argon 
purge) CH2Cl2 (40 mL) at room temperature with stirring. The resulting suspension was 
then immediately heated to reflux at 50 °C. After 2 h the reaction mixture was removed 
from heat and left to cool before being concentrated in vacuo. The dark red-brown residue 
was then purified directly by flash chromatography (silica gel, EtOAc/hexanes, 0% to 20%) 
to give acid ester 15 (1.527 g, 96%) as a clear, pale brown oil. 
        = –11.2 (c = 1, CHCl3); ee found as 96% by HPLC (Daicel Chiralpak IC 
column, 0.46 cm × 25 cm, 5% i-PrOH/hexane, 0.75 mL/min,  major = 19.3 min,  minor = 16.8 
min); IR (neat) νmax 1713 (C-16, C=O), 1702 (C-21, C=O), 1651 (C=C) cm-1; 1H NMR (400 
MHz, CDCl3) δ 6.89 (dt, J = 15.6, 7.0 Hz, 1H, H-14), 5.87 (d, J = 15.6 Hz, 1H, H-17), 4.18 
(q, J = 7.1 Hz, 2H, -OCH2CH3), 2.60 – 2.45 (m, 2H, H-15), 2.42 – 2.35 (m, 1H, H-20), 1.73 
– 1.59 (m, 2H, H-19), 1.28 (t, J = 7.1 Hz, 3H, -OCH2CH3), 0.96 (t, J = 7.4 Hz, 3H, H-18); 
13C NMR (101 MHz, CDCl3) δ 180.7 (C-21), 166.5 (C-16), 145.4 (C-14), 123.6 (C-17), 60.5 
(C-20), 45.7 (-OCH2CH3), 33.7 (C-15), 24.8 (C-19), 14.4 (-OCH2CH3), 11.5 (C-18); HRMS 
(ESI) calcd for C10H16O4Na+ [M + Na]+ requires 223.0946, found 223.0941.  
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Sulfanyl amides 167 
 
 Acid ester 15 (940 mg, 4.70 mmol, 1.0 equiv) was dissolved in CH2Cl2 (90 mL) and 
cooled to 0 °C before a sequence of N,N'-dicyclohexylcarbodiimide (1.065 g, 5.16 mmol, 
1.1 equiv), 1-hydroxybenzotriazole (698 mg, 5.16 mmol, 1.1 equiv) and 3,4-dihydro--
carboline (959 mg, 5.63 mmol, 1.2 equiv) was added to the solution with stirring. After 1 h 
the reaction mixture was cooled to –78 °C and BF3·OEt2 (0.77 mL, 6.10 mmol, 1.3 equiv) 
was added followed by the addition of thiophenol (0.63 mL, 6.10 mmol, 1.3 equiv) and the 
mixture slowly left to warm to –50 °C over a 1 h period. The reaction mixture was then 
quenched by the addition of saturated aqueous NaHCO3 (50 mL) before the contents were 
transferred into a separatory funnel and diluted with another 50 mL of aqueous NaHCO3 
and 100 mL CH2Cl2. The organic layer was extracted and the aqueous layer washed a 
further three times with CH2Cl2 (100 mL). The combined organic layers were dried with 
MgSO4, filtered and concentrated in vacuo. Cold Et2O (100 mL) was then added to the 
grainy residue before being filtered through a pad of Celite and concentrated in order to 
remove the thiourea by-product. This cold filtration process was then repeated a further 
two times. The resulting residue was purified carefully by flash chromatography (silica gel, 
EtOAc/hexanes, 0% to 20%) to give a mixture of diastereomers with two amide rotamers 
each (1.985 g, 91%) as a clear, colourless foam 16.   
        = –8.9 (c = 1, CHCl3); IR (neat) νmax 2969 (N-H), 1781 (C-16, C=O), 1701 (C-
21, C=O) cm-1; 1H NMR (400 MHz, CDCl3) δ 8.32, 8.23, 8.17, 8.11 (s, 1H, N-H), 7.54 – 
7.21 (m, 5H, SPh-H), 7.48 – 7.45, 7.33 – 7.29, 7.22 – 7.19, 7.16 – 7.09 (m, 4H, {H-9 to H-
12}), 7.42, 7.38, 6.44, 6.34 (s, 1H, H-3), 6.85, 6.81, 6.64, 6.51 (dt, J = 15.6, 7.4 Hz, 1H, H-
14), 5.85, 5.76, 5.71, 5.57 (d, J = 15.6 Hz, 1H, H-17), 4.96 – 4.89, 4.11 – 4.08, 3.83 – 3.78, 
3.31 – 3.22 (m, 2H, H-5), 4.23 – 4.19, 4.00 – 3.95, 3.90 – 3.85, 3.61 – 3.55 (m, 2H, -
OCH2CH3), 2.85 – 2.75 (m, 2H, H-6), 2.82 – 2.78, 2.24 – 2.18 (m, 1H, H-20), 2.55 – 2.50, 
2.41 – 2.36, 2.32 – 2.27, 2.24 – 2.19, 1.97 – 1.92 (m, 2H, H-15), 1.71 – 1.64, 1.63 – 1.57, 
1.52 – 1.45, 1.35 – 1.31 (m, 2H, H-19), 1.31, 1.30, 1.06, 0.92 (t, J = 7.1 Hz, 3H, -
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OCH2CH3), 0.81, 0.77, 0.65, 0.55 (t, J = 7.4 Hz, 3H, H-18); 13C NMR (101 MHz, CDCl3) δ 
{174.0, 173.8, 173.6, 173.5 (C-21)}, {166.6, 166.4, 166.2, 165.7 (C-16)}, {146.8, 145.9, 
145.9, 144.3 (C-14)}, 136.7, 136.5, 136.5, 136.3, 136.2, 134.3, 133.9, 132.5, 132.5, 131.5, 
131.5, 130.6, 130.4, 129.9, 129.8, 129.7, 129.4, 129.3, 129.0, 128.5, 128.4, 126.5, 126.5, 
126.4, 126.4, {123.8, 123.5, 123.5, 123.2 (C-17)}, 123.3, 123.1, 122.9, 122.9, 120.2, 
119.9, 119.9, 119.0, 118.9, 118.6, 118.5, 111.5, 111.4, 110.2, 110.2, {62.6, 62.6, 58.0, 
57.9 (C-3)}, {60.5, 60.3, 60.3, 60.2 (-OCH2CH3)}, {42.9, 42.6, 42.6, 41.5 (C-20)}, {40.2, 
40.2, 36.6, 36.4 (C-5)}, {35.2, 34.6, 33.7 (C-15)}, {25.8, 25.3, 25.2, 25.1, (C-19)}, {22.6, 
22.6, 21.3, 21.1 (C-6)}, {14.4, 14.2, 14.0 (-OCH2CH3)}, {11.8, 11.3, 10.8 (C-18)}; HRMS 
(ESI) calcd for C21H25N2O3+ [M – SPh]+ requires 353.1865, found 353.1875. 
 
N-Boc protected sulfanyl amides 177 
 
 Di-tert-butyl dicarbonate (1.492 g, 6.83 mmol, 1.3 equiv) followed by 4-
dimethylaminopyridine (32 mg, 0.263 mmol, 0.05 equiv) was added to a solution of 
sulfanyl amides 16 (2.432 g, 5.26 mmol, 1.0 equiv) in THF (30 mL) at room temperature 
with stirring. After 2 h the reaction mixture was concentrated in vacuo and the residue 
purified by flash chromatography (silica gel, EtOAc/hexanes, 0% to 25%) to give a mixture 
of diastereomers and amide rotamers 17 in quantitative yield (2.957 g) as a white paste. 
        = +10.1 (c = 1, CHCl3); IR (neat) νmax 1737 (Boc, C=O), 1721 (C-16, C=O), 
1648 (C-21, C=O) cm-1; 1H NMR (400 MHz, CDCl3) δ 8.20 – 8.18, 8.03 – 8.00, 7.68 – 7.66, 
7.50 – 7.30, 7.28 – 7.20 (m, 9H, {H-9 to H-12, SPh-H}), 8.03, 8.00, 7.26, 7.23 (s, 1H, H-3), 
6.83 – 6.76, 6.69 – 6.64, 6.41 – 6.36 (m, 1H, H-14), 5.78, 5.77, 5.64, 5.56 (d, J = 15.6 Hz, 
1H, H-17), 4.96 – 4.89, 4.14 – 4.08, 4.04 – 4.01, 3.74 – 3.66 (m, 2H, H-5), 4.22 – 4.16, 
4.00 – 3.94, 3.87 – 3.81, 3.44 – 3.39, 3.17 – 3.11 (m, 2H, -OCH2CH3), 2.83 – 2.74 (m, 2H, 
H-6), 2.82 – 2.72, 2.25 – 2.19, 2.15 – 2.08 (m, 1H, H-20), 2.55 – 2.49, 2.33 – 2.08,  
78 
 
1.85 – 1.81 (m, 2H, H-15), 1.81, 1.79, 1.70, 1.69 (s, 3H, -OC(CH3)3), 1.72 – 1.14 (m, 2H, 
H-19), 1.32, 1.28, 1.07, 0.89 (t, J = 7.1 Hz, 3H, -OCH2CH3), 0.82, 0.69, 0.64, 0.39 (t, J = 
7.4 Hz, 3H, H-18); 13C NMR (101 MHz, CDCl3) δ {173.7, 173.7, 173.4 (C-21)}, {166.6, 
166.4, 166.3, 165.3 (C-16)}, {150.1, 150.0, 149.6 (-CO2tBu)}, {147.0, 146.0, 145.9, 144.5 
(C-14)}, 136.7, 136.7, 136.4, 136.3, 136.2, 136.0, 133.7, 133.6, 132.9, 132.8, 132.3, 131.9, 
131.3, 131.2, 131.0, 129.6, 129.6, 129.5, 129.3, 128.9, 128.3, 128.1, 128.1, 127.6, 127.5, 
125.3, 125.2, 125.1, 123.7, 123.4, 123.4, 123.1, 123.0, 123.0, 122.9, 122.8, 118.9, 118.7, 
118.5, 118.5, 118.3, 118.2, 116.5, 116.4, 116.0, 115.9, 115.8, 115.7, {84.8, 84.7, 84.5 (-
OC(CH3)3)}, {64.6, 64.4, 58.1, 58.0 (C-3)}, {60.4, 60.3, 59.7 (-OCH2CH3)}, {42.7, 42.7, 
42.6, 41.4 (C-20)}, {38.6, 35.6, 35.1, 34.7 (C-5)}, {34.8, 34.6, 33.8 (C-15)}, {28.5, 28.5, 
28.4, 28.3 (-OC(CH3)3)}, {25.8, 25.2, 25.0 (C-19)}, {22.3, 22.3, 20.8, 20.7 (C-6)}, {14.5, 
14.4, 14.2, 14.1 (-OCH2CH3)}, {12.0, 11.5, 11.3, 10.8 (C-18)}; HRMS (ESI) calcd for 
C26H33N2O5+ [M – SPh]+ requires 453.2389, found 453.2396. 
 
Lactam major-187 
 
 To a solution of N-Boc protected sulfanyl amides 17 (2.824 g, 5.02 mmol, 1.0 equiv) 
in dry, degassed (by 30 min argon purge) toluene (220 mL) was added n-Bu3SnH (1.75 
mL, 6.52 mmol, 1.3 equiv) and the mixture immediately heated to reflux. Once the reaction 
mixture was refluxing vigorously a solution of 1,1'-azobis(cyclohexanecarbonitrile) (123 
mg, 0.502 mmol, 0.1 equiv) in dry, degassed (by 30 min argon purge) toluene (30 mL) was 
slowly added over 1 h. After refluxing for a further 2 h the reaction mixture was left to cool 
to room temperature before being concentrated in vacuo. The resulting residue was very 
carefully chromatographed (silica gel, EtOAc/hexanes, 0% to 20%) to give major cis-18 
(2.052 g, 85% corrected yield) and minor trans-18 (144 mg, 8% corrected yield) 
diastereomers as clear, colourless gums (dr = 10:1). The data that follows is for the major 
cis-18 diastereomer which was isolated with ~11% of the minor trans-18 diastereomer 
present. 
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        = +159.9 (c = 1, CHCl3); IR (neat) νmax 1732 (Boc, C=O), 1722 (C-16, C=O), 
1665 (C-21, C=O) cm-1; 1H NMR (400 MHz, CDCl3) δ 8.10 (d, J = 8.2 Hz, 1H, H-12), 7.47 
– 7.44 (m, 1H, H-9), 7.31 (td, J = 7.4, 1.4 Hz, 1H, H-10), 7.26 (td, J = 7.4, 1.2 Hz, 1H, H-
11), 5.47 (br d, J = 3.6 Hz, 1H, H-3), 4.88 – 4.83 (m, 1H, H-5b), 3.81 – 3.72 (m, 1H, -
OCH2CH3), 3.62 – 3.54 (m, 1H, -OCH2CH3), 3.25 – 3.16 (m, 1H, H-14), 2.95 – 2.87 (m, 
1H, H-5a), 2.88 – 2.87 (m, 1H, H-6b), 2.71 – 2.67 (m, 1H, H-6a), 2.50 (ddd, J = 13.7, 9.6, 
7.5 Hz, 1H, H-15b), 2.38 – 2.31 (m, 1H, H-20), 2.08 – 2.01 (m, 1H, H-19b), 1.96 (dd, J = 
15.9, 8.6 Hz, 1H, H-17b), 1.88 (dd, J = 15.9, 6.1 Hz, 1H, H-17a), 1.73 (br s, 9H, -
OC(CH3)3), 1.44 – 1.37 (m, 1H, H-19a), 1.12 – 1.07 (m, 1H, H-15a), 1.02 (t, J = 7.5 Hz, 3H, 
H-18), 0.99 (t, J = 7.1 Hz, 3H, -OCH2CH3); 13C NMR (101 MHz, CDCl3) δ 175.0 (C-16), 
172.1 (C-21), 150.2 (-CO2tBu), 136.6 (C-13), 131.8 (C-2), 128.1 (C-8), 124.9 (C-11), 123.2 
(C-10), 119.4 (C-9), 118.3 (C-12), 116.2 (C-7), 84.7 (-OC(CH3)3), 60.4 (-OCH2CH3), 54.2 
(C-3), 40.8 (C-20), 38.3 (C-5), 36.7 (C-17), 34.1 (C-14), 31.3 (C-15), 28.4 (-OC(CH3)3), 
23.7 (C-19), 20.5 (C-6), 14.0 (-OCH2CH3), 12.1 (C-18); HRMS (ESI) calcd for C26H35N2O5+ 
[M + H]+ requires 455.2548, found 455.2554. 
 
Deprotected lactam 308 
 
 Neat lactam cis-18 (101 mg, 0.222 mmol, 1.0 equiv) containing a small amount of 
minor trans-18 was heated at a temperature of 180 °C for a period of 30 min, after which 
the deprotection reaction was shown to be complete by TLC analysis. The residue was 
then left to cool to room temperature and purified immediately by flash chromatography 
(silica gel, EtOAc/hexanes, 0% to 40%) to give deprotected major lactam cis-30 (73 mg, 
87% corrected yield) as a clear, pale yellow gum. The presence of trace amounts of minor 
deprotected lactam trans-30 still allowed for the clean isolation of (+)-tacamonine later on. 
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        = +83.1 (c = 1, CHCl3); IR (neat) νmax 1726 (C-16, C=O), 1654 (C-21, C=O) 
cm-1; 1H NMR (400 MHz, CDCl3) δ 7.96 (br s, 1H, N-H), 7.51 (d, J = 8.4 Hz, 1H, H-12), 
7.36 – 7.32 (m, 1H, H-9), 7.21 – 7.17 (m, 1H, H-10), 7.15 – 7.11 (m, 1H, H-11), 4.93 (d, J = 
4.1 Hz, 1H, H-3), 4.67 – 4.62 (m, 1H, H-5b), 3.99 – 3.91 (m, 1H, -OCH2CH3), 3.87 – 3.78 
(m, 1H, -OCH2CH3), 3.22 – 3.15 (m, 1H, H-5a), 2.95 – 2.91 (m, 1H, H-14), 2.86 – 2.79 (m, 
2H, H-6), 2.46 – 2.38 (m, 1H, H-15b), 2.42 – 2.37 (m, 1H, H-20), 2.14 – 2.08 (m, 1H, H-
17b), 2.10 – 2.06 (m, 1H, H-19b), 2.06 – 2.01 (m, 1H, H-17a), 1.47 – 1.41 (m, 1H, H-19a), 
1.35 – 1.29 (m, 1H, H-15a), 1.07 (t, J = 7.1 Hz, 3H, -OCH2CH3), 1.01 (t, J = 7.2 Hz, 3H, H-
18); 13C NMR (101 MHz, CDCl3) δ 174.6 (C-16), 172.8 (C-21), 136.8 (C-13), 130.4 (C-2), 
126.7 (C-8), 122.6 (C-11), 120.1 (C-10), 118.5 (C-9), 112.2 (C-12), 111.3 (C-7), 60.8 (-
OCH2CH3), 54.2 (C-3), 41.1 (C-20), 39.9 (C-5), 35.8 (C-17), 34.8 (C-14), 30.2 (C-15), 24.4 
(C-19), 20.5 (C-6), 14.1 (-OCH2CH3), 12.2 (C-18); HRMS (ESI) calcd for C21H27N2O3+ [M + 
H]+ requires 355.2023, found 355.2025. 
 
Alcohol 319 
 
 To a solution of deprotected lactam 30 (91 mg, 0.257 mmol, 1.0 equiv) in THF (10 
mL) at –40 °C was added alane N,N-dimethylethylamine complex (0.5 M solution in 
toluene, 2.05 mL, 1.03 mmol, 4.0 equiv) dropwise over 30 min. The reaction mixture was 
left to stir at this temperature for 30 min before being allowed to warm to 0 °C. After stirring 
for a further 5 h at this temperature the reaction mixture was quenched by the careful 
addition of saturated Na2SO4 (2 mL) and filtered through a pad of Celite. The solid residue 
was washed with a large amount of 5% MeOH/CH2Cl2. The filtrate was then dried over 
MgSO4 and concentrated in vacuo to give alcohol 31 (48 mg, 63% crude) as a yellowish 
residue that was used in the next step without further purification.   
 IR (neat) νmax 3353 (O-H stretching), 1415 (O-H bending), 1054  
(C-O stretching) cm-1. 
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(+)-Tacamonine (1)10 
 
 To a solution of crude 31 (48 mg, 0.161 mmol, 1.0 equiv) and a small amount of 4 Ǻ 
molecular sieves (15 mg) in CH2Cl2 (5 mL) was added N-methylmorpholine N-oxide (38 
mg, 0.322 mmol, 2.0 equiv) followed by tetrapropylammonium perruthenate (11 mg, 0.032 
mmol, 0.2 equiv) 10 min later with stirring at room temperature. After 3 h the resulting 
mixture was filtered through a small pad of Celite and washed with a large amount of 
CH2Cl2. The filtrate was transferred to a separatory funnel and washed with saturated 
Na2SO3 (5 mL), brine (5 mL), and saturated CuSO4 (5 mL). The organic layer was 
separated, dried and concentrated. The dark brown residue was purified by flash 
chromatography (silica gel, MeOH/CH2Cl2, 0% to 5%) to afford (+)-tacamonine (34 mg, 
45% yield over 2 steps) as colourless needles. The data given below is in agreement with 
literature reports.1,11,12    
 Mp = 179 – 181 °C (Literature1 = 180 – 181 °C);        = +117.2 (Literature
11 = +122, 
c = 0.2, CHCl3); ee found as 96% by HPLC (Daicel Chiralcel OD column, 0.46 cm × 25 cm, 
50% i-PrOH/hexane, 0.5 mL/min,  major = 22.6 min,  minor = 25.0 min); IR (neat) νmax 1701 
(C-16, C=O) cm-1; 1H NMR (400 MHz, CDCl3) δ 8.38 (br dd, J = 7.3, 1.6 Hz, 1H, H-12), 
7.46 – 7.43 (m, 1H, H-9), 7.35 – 7.27 (m, 2H, H-10 and H-11), 4.42 – 4.38 (m, 1H, H-3), 
3.42 – 3.33 (m, 2H, H-5), 3.01 (dd, J = 17.0, 4.9 Hz, 1H, H-17b), 2.97 – 2.87 (m, 1H, H-6b), 
2.71 – 2.66 (m, 1H, H-21b), 2.68 (dd, J = 17.0, 2.2 Hz, 1H, H-17a), 2.57 – 2.49 (m, 1H, H-
6a), 2.54 – 2.47 (m, 1H, H-14), 2.07 (t, J = 11.0 Hz, 1H, H-21a), 1.71 – 1.66 (m, 1H, H-15b), 
1.63 – 1.54 (m, 1H, H-20), 1.16 – 1.08 (m, 2H, H-19), 0.86 (t, J = 7.4 Hz, 3H, H-18), 0.58 
(ddd, J = 12.9, 12.8, 12.7 Hz, 1H, H-15a); 13C NMR (101 MHz, CDCl3) δ 167.4 (C-16), 
134.7 (C-13), 131.4 (C-2), 130.0 (C-8), 124.7 (C-11), 124.1 (C-10), 118.3 (C-9), 116.5 (C-
12), 112.9 (C-7), 53.5 (C-3), 50.7 (C-21), 50.4 (C-5), 39.8 (C-17), 37.6 (C-20), 34.5 (C-14), 
32.0 (C-15), 27.0 (C-19), 16.5 (C-6), 11.4 (C-18); HRMS (ESI) calcd for C19H23N2O+ [M + 
H]+ requires 295.1812, found 295.1820. 
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  3.2 X-Ray Crystal Structure Determination 
 Single crystal X-ray analysis of the pentacycle 19 and the target 1 was carried out in 
collaboration with Dr. Hong Su who is a scientific officer in the Centre for Supramolecular 
Chemistry Research at the University of Cape Town.   
 
 A single crystal of the pentacycle 19 and the target 1 were covered in a small 
amount of paratone oil and mounted on a glass fibre. Single-crystal X-ray diffraction data 
were collected on a Bruker KAPPA APEX II DUO diffractometer using graphite-
monochromated Mo-K radiation ( = 0.71073 Å). Data collection was carried out at 
173(2) K. Temperature was controlled by an Oxford Cryostream cooling system (Oxford 
Cryostat). Cell refinement and data reduction were performed using the program SAINT.13 
The data were scaled and absorption correction performed using SADABS.14 The structure 
was solved by direct methods using SHELXS-9714 and refined by full-matrix least-squares 
methods based on F2 using SHELXL-201414 and using the graphics interface program X-
Seed.15 The programs X-Seed and POV-Ray were both used to prepare molecular graphic 
images. All non-hydrogen atoms were refined anisotropically. All hydrogen atoms were 
placed in idealised positions and refined in riding models with Uiso assigned 1.2 or 1.5 
times Ueq of their parent atoms and the bond distances were constrained from 0.95 to 1.00 
Å. The structure was refined to R factor of 0.0368. Flack x = 0.217(999) by classical fit to 
all intensities; -0.701(660) from 1418 selected quotients (Parsons' method). Absolute 
structure cannot be determined reliably. The parameters for crystal data collection and 
structure refinements, the bond lengths, angles, torsion angles are beyond the scope of 
this work and have thus not been included for brevity. 
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  3.3 Computational Methods 
 Computational modelling of the radical cyclization step was carried out in 
collaboration with Dr. Gerhard Venter who is an assistant director in the Scientific 
Computing Research Unit as well as a senior lecturer in the Department of Chemistry at 
the University of Cape Town.    
 
 The DFT calculations were done with the Gaussian 16 software package.16 The 
conformational search was done with the confab module17 as implemented in 
OpenBabel,18 using the MMFF94 force field.19 The structures were optimized using the 
TPSS DFT functional20 and the def2-TZVP basis set.21 The D3 dispersion correction of 
Grimme et al., with the Becke-Johnson damping function,22 was added. This level of theory 
is denoted as TPSS-D3(BJ)/def2-TZVP. Solvent affects were taken into account using the 
SMD model with default parameters for toluene.23 Following the geometry optimization, 
single point energies were computed using the PW6B95 functional24 and the larger def2-
QZVP basis set,21 again adding the D3 dispersion correction of Grimme et al.22 (i.e. 
PW6B95-D3(BJ)/def2-QZVP). Thermal corrections to the energy were added using the 
standard rigid-rotor harmonic-oscillator (RRHO) approximations with frequencies 
computed at the TPSS-D3/def2-TZVP level of theory. All stationary points were 
characterized as either minima (no imaginary frequencies) or saddle-points (a single 
imaginary frequency). It was visually confirmed that the saddle-points are connected to the 
expected reactants and products by animating the normal mode associated with the 
imaginary frequency. All calculations were run using computational resources provided by 
the Centre for High Performance Computing (CHPC), South Africa. 
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